Domain > www.ejgo.net

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2024-10-01	18.155.192.76 (ClassC)
2025-08-01	3.163.24.79 (ClassC)

HTTP/1.1 200 OKContent-Type: text/html; charsetutf-8Content-Length: 196524Connection: keep-aliveServer: nginxDate: Fri, 01 Aug 2025 19:42:58 GMTAccept-Ranges: bytesVary: Accept-EncodingVary: Accept-EncodingETag: 2ffac-Dyja7RVxdQ6WPoPyTuEGknQXSeEStrict-Transport-Security: max-age63072000; preloadX-Cache: Miss from cloudfrontVia: 1.1 518bdec7a5119a665abaf6315a08e6a8.cloudfront.net (CloudFront)X-Amz-Cf-Pop: HIO52-P2X-Amz-Cf-Id: l4ZSfM_L4goQsCBH72-y1ff-9NhKiMU7Qw7FDczrdFlb_SnLeyqafAVary: Origin

!doctype html>html data-n-head-ssr langen-US data-n-head%7B%22lang%22:%7B%22ssr%22:%22en-US%22%7D%7D>  head >    title>European Journal of Gynaecological Oncology (EJGO)/title>meta data-n-headssr charsetutf-8>meta data-n-headssr nameviewport contentwidthdevice-width, initial-scale1>meta data-n-headssr data-hidkeywords namekeywords contentOncology, Journal of Surgical Oncology, JAMA Oncology, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Breast Cancer Research and Treatment, European Journal of Gynaecological Oncology, 0392-2936>meta data-n-headssr data-hiddescription namedescription contentEuropean Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal, which is currently indexed in SCIE, etc. It covers many aspects of gynaecologic oncology topics, including Cervical Cancer, Fallopian Tube Cancer, Breast Cancer etc.>link data-n-headssr relicon typeimage/x-icon href/icon.png>script data-n-headssr srchttps://echo.mrepress.net/cat.js async data-website-idfb696409-691a-4544-8d9d-b9aaa9a6aed6>/script>script data-n-headssr typetext/javascript src//platform.twitter.com/widgets.js async>/script>link relpreload href/_nuxt/eec1a6e9a5a74f9cf488.js asscript>link relpreload href/_nuxt/db6bf579df3e706bbe99.js asscript>link relpreload href/_nuxt/86e9591c0a129192ff55.js asscript>link relpreload href/_nuxt/c4dd8d6bc7da3647faef.js asscript>link relpreload href/_nuxt/d9cbb78c020534e75640.js asscript>style data-vue-ssr-id14a41a40:0 f52d43e0:0 3191d5ad:0 932a8f60:0 74ab325a:0 26178a6d:0 439d0109:0 0b68dcbc:0 0eead860:0 a36fd414:0 623f7943:0 ed122494:0 2b1a7e72:0 1083075a:0 5ee4613a:0 7ae3f03a:0 7f1b6fce:0 72edf7fc:0 d2025922:0 546a6b7e:0>html{font-size:14px;overflow-y:auto;height:100%;background-color:#ebf0f4}body,html{width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);-webkit-overflow-scrolling:touch;overflow-scrolling:touch}body{font:1rem Arial,Helvetica Neue,Helvetica,PingFang SC,Hiragino Sans GB,Microsoft Yahei,sans-serif;position:relative;color:#333;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;text-rendering:optimizeLegibility}a,div,input,p,span{font-size:14px}a{cursor:pointer}body,button,dd,dl,figure,form,h1,h2,h3,h4,h5,h6,input,ol,p,td,textarea,th,ul{margin:0;padding:0}input,select,textarea{box-sizing:content-box}table{border-spacing:0;border-collapse:collapse}button,img,input,textarea{border:none}input{text-align:inherit}textarea{resize:none}a,button,h1,h2,h3,h4,h5,h6,input,optgroup,option,select,textarea{font-family:inherit;font-size:inherit;font-weight:inherit;font-style:inherit;line-height:inherit;color:inherit;outline:none}a{text-decoration:none}nav,ol,ul{list-style:none}button,inputtypebutton,inputtypesubmit{cursor:pointer}input::-moz-focus-inner{padding:0;border:0}inputtypenumber{-moz-appearance:textfield}inputtypenumber::-webkit-inner-spin-button,inputtypenumber::-webkit-outer-spin-button{margin:0;-webkit-appearance:none}input::-webkit-input-placeholder,textarea::-webkit-input-placeholder{color:#999}input:-moz-placeholder,input::-moz-placeholder,textarea:-moz-placeholder,textarea::-moz-placeholder{color:#999}input:-ms-input-placeholder,textarea:-ms-input-placeholder{color:#999}template{display:none}.c{zoom:1}.c:after{display:block;visibility:hidden;clear:both;height:0;content:.}.pf{position:fixed;-webkit-transform:translateZ(0)}.middle{position:absolute;top:0;right:0;bottom:0;left:0;margin:auto}.v-middle{position:relative;top:50%;transform:translateY(-50%)}.bb{box-sizing:border-box}.to{overflow:hidden;white-space:nowrap;text-overflow:ellipsis}h1,h1 p{color:#5055a6}.ql-snow h1,h1,h1 p{font-size:24px;font-weight:700;margin:10px 0 30px}.ql-snow h1,h1 p{color:#333}h2{font-size:18px;font-weight:700;margin-top:10px;margin-bottom:16px;position:relative}h2>a{font-size:14px;color:#5297cc;position:absolute;right:0}h3{font-size:16px}h3,h4{font-weight:700}h4{font-size:14px}.container{width:100%}#breadcrumb,#layout{width:1200px;margin:0 auto}.block{background:#fff;padding:20px;border-radius:6px}.mar-8{margin:8px 0}.mar-16{margin:16px 0}.mar-30{margin:30px 0}.str{font-weight:700}p{line-height:24px;font-size:14px}.text-j{text-align:justify}.inline-svg{display:inline-flex;justify-content:center;align-items:center;vertical-align:bottom}.inline-svg svg{height:16px;width:16px;margin-right:8px}.max-height-after{position:relative}.max-height-after:after{content:;position:absolute;bottom:-20000px;height:20000px;background:#fff;width:100%;left:0}.be-red{color:#5055a6}.be-blue{color:#5297cc}.sv-input{width:300px;line-height:30px;padding:0 12px}.sv-input,.sv-textarea{background:#fff;border:1px solid #b7b7b7;border-radius:6px;margin:12px 0;box-sizing:border-box}.sv-textarea{width:100%;padding:5px 12px}.border-radius{border-radius:6px}.nuxt-progress{position:fixed;top:0;left:0;right:0;height:2px;width:0;opacity:1;transition:width .1s,opacity .4s;background-color:#fff;z-index:999999}.nuxt-progress.nuxt-progress-notransition{transition:none}.nuxt-progress-failed{background-color:red}html{font-family:Source Sans Pro,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,sans-serif;font-size:16px;word-spacing:1px;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;-moz-osx-font-smoothing:grayscale;-webkit-font-smoothing:antialiased;box-sizing:border-box}*,:after,:before{box-sizing:border-box;margin:0}.button--green{display:inline-block;border-radius:4px;border:1px solid #3b8070;color:#3b8070;text-decoration:none;padding:10px 30px}.button--green:hover{color:#fff;background-color:#3b8070}.button--grey{display:inline-block;border-radius:4px;border:1px solid #35495e;color:#35495e;text-decoration:none;padding:10px 30px;margin-left:15px}.button--grey:hover{color:#fff;background-color:#35495e}#homepage>.contentdata-v-c17c85d0{display:flex;width:1200px;margin:0 auto}#homepage>.content>.maindata-v-c17c85d0{width:924px;margin-right:16px}#homepage>.content>.main .middle-contentdata-v-c17c85d0{display:flex;margin:16px 0}#homepage>.content>.main .middle-content>divdata-v-c17c85d0{width:454px;overflow:hidden;border-radius:6px}#homepage>.content>.main .middle-content>div .hotNewsdata-v-c17c85d0{position:relative;font-size:0;height:260px}#homepage>.content>.main .middle-content>div .hotNews adata-v-c17c85d0{display:block;width:100%;height:100%}#homepage>.content>.main .middle-content>div .hotNews a imgdata-v-c17c85d0{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}#homepage>.content>.main .middle-content>div .hotNews a pdata-v-c17c85d0{position:absolute;left:0;bottom:0;height:70px;width:100%;display:flex;align-items:center;justify-content:center;background:rgba(51,51,51,.4);color:#fff;font-weight:700;padding:20px;text-align:center}#homepage>.content>.main .middle-content>div .btnsdata-v-c17c85d0{line-height:30px;background:#c9d1d6;border-radius:6px;width:auto;display:inline-block;overflow:hidden}#homepage>.content>.main .middle-content>div .btns adata-v-c17c85d0{display:inline-block;padding:0 16px}#homepage>.content>.main .middle-content>div .btns a.activedata-v-c17c85d0{background:#5297cc;color:#fff}#homepage>.content>.main .middle-content>div .special-issues .special-issues-itemdata-v-c17c85d0{padding:16px 0;border-bottom:1px solid #d6d6d6}#homepage>.content>.main .middle-content>div .special-issues .special-issues-item h4data-v-c17c85d0{color:#5297cc;line-height:24px}#homepage>.content>.main .middle-content>div .special-issues .special-issues-item spandata-v-c17c85d0{color:#878787;font-weight:700}#homepage>.content>.main .middle-content>div .special-issues .special-issues-item pdata-v-c17c85d0{line-height:30px;width:414px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}#homepage>.content>.main .middle-content>div .special-issues .special-issues-item p spandata-v-c17c85d0{vertical-align:top}#homepage>.content>.main .middle-content>div .special-issues .special-issues-itemdata-v-c17c85d0:hover{background-color:#ebf0f4}#homepage>.content>.main .middle-content>div .special-issues .special-issues-itemdata-v-c17c85d0:last-child{border:none}#homepage>.content>.main .middle-content>div .preprintsdata-v-c17c85d0{position:relative;padding-bottom:0}#homepage>.content>.main .middle-content>div .preprints .preprints-itemdata-v-c17c85d0{padding:16px 0;border-bottom:1px solid #d6d6d6}#homepage>.content>.main .middle-content>div .preprints .preprints-item h4data-v-c17c85d0{color:#5297cc;margin-bottom:8px}#homepage>.content>.main .middle-content>div .preprints .preprints-item pdata-v-c17c85d0{color:#878787;line-height:30px;margin-bottom:8px}#homepage>.content>.main .middle-content>div .preprints .preprints-item p spandata-v-c17c85d0{vertical-align:top}#homepage>.content>.main .middle-content>div .preprints .preprints-itemdata-v-c17c85d0:last-child{border:none}#homepage>.content>.main .middle-content>div .preprintsdata-v-c17c85d0:after{content:;position:absolute;width:100%;height:3000px;bottom:-3000px;left:0;background:#fff}#homepage>.content>.main .middle-content>div .tweets h4data-v-c17c85d0{color:#5297cc;margin:16px 0}#homepage>.content>.main .middle-content>div .tweets pdata-v-c17c85d0{line-height:24px}#homepage>.content>.main .middle-content>div .tweets spandata-v-c17c85d0{display:block;text-align:right}#homepage>.content>.main .middle-content>div .tweets imgdata-v-c17c85d0{width:320px;max-height:240px;display:block;-o-object-fit:contain;object-fit:contain;margin:20px auto;border-radius:4px}#homepage>.content>.main .middle-content>div .rewiewerdata-v-c17c85d0{position:relative}#homepage>.content>.main .middle-content>div .rewiewer adata-v-c17c85d0{width:100%;line-height:46px;display:block;text-align:center;background:#5055a6;color:#fff;border-radius:6px;margin:20px 0;font-size:18px}#homepage>.content>.main .middle-content>div .joindata-v-c17c85d0:after{content:;position:absolute;width:100%;height:300px;bottom:-300px;left:0;background:#fff}#homepage>.content>.main .middle-content>divdata-v-c17c85d0:last-child{margin-left:16px}#homepage>.content>asidedata-v-c17c85d0{width:260px;overflow:hidden}#homepage .changeScrollBtndata-v-c17c85d0{display:flex;position:absolute;right:0;top:0;align-items:center}#homepage .changeScrollBtn svgdata-v-c17c85d0{margin:0 8px}#homepage .changeScrollBtn adata-v-c17c85d0{color:#5297cc}.foot-block{display:flex;padding:30px 20px;border-bottom:1px solid #d6d6d6}.foot-block img{width:160px;height:180px;-o-object-fit:cover;object-fit:cover;margin-right:20px}.foot-block div{width:690px}.foot-block:last-child{border-bottom:none}#headerdata-v-74a6fc2e{border-radius:6px;min-width:100%}#headerdata-v-74a6fc2e,#header .topdata-v-74a6fc2e{width:75rem;margin:0 auto}#header .topdata-v-74a6fc2e{display:flex;padding:0 20px;height:90px;position:relative}#header .top .logodata-v-74a6fc2e{display:flex;font-size:24px;align-items:center;padding-right:10px}#header .top .logo svgdata-v-74a6fc2e{height:100%;margin-right:16px}#header .top .logo .logo-detaildata-v-74a6fc2e{display:inline-block}#header .top .logo h1data-v-74a6fc2e{font-size:24px;color:#bf3949;margin:0;font-family:思源宋体}#header .top .site-titledata-v-74a6fc2e{font-weight:400;font-size:20px;line-height:40px;align-self:center;font-family:思源宋体}#header .top .searchdata-v-74a6fc2e{height:100%;text-align:right;position:absolute;right:100px;font-size:16px;line-height:90px;display:flex}#header .top .search .menus2data-v-74a6fc2e{font-size:400;height:40px;line-height:40px;align-self:center;margin-right:10px}#header .top .search .menus2>uldata-v-74a6fc2e{display:flex}#header .top .search .menus2>ul lidata-v-74a6fc2e{display:flex;padding:0 15px;align-items:center;cursor:pointer;position:relative}#header .top .search .menus2>ul li svgdata-v-74a6fc2e{width:12px;margin-left:8px}#header .top .search .menus2>ul li .second-menusdata-v-74a6fc2e{overflow:hidden;position:absolute;z-index:999;width:230px;top:40px;left:0;background:#777ccd}#header .top .search .menus2>ul li .second-menus lidata-v-74a6fc2e{height:0;transition:all .3s}#header .top .search .menus2>ul li.journals-menu-item .second-menusdata-v-74a6fc2e{width:365px}#header .top .search .menus2>ul lidata-v-74a6fc2e:hover{color:#2a34cc}#header .top .search .menus2>ul li:hover .second-menus lidata-v-74a6fc2e{height:45px;line-height:25px;text-align:left;color:#000}#header .top .search .menus2>ul li:hover .second-menus lidata-v-74a6fc2e:hover{color:#fff}#header>.doi_title_pdata-v-74a6fc2e{background-color:#777ccd}#header>.doi_title_p>.doi_titledata-v-74a6fc2e{height:80px;width:1200px;margin:0 auto;display:flex}#header>.doi_title_p>.doi_title .input1data-v-74a6fc2e,#header>.doi_title_p>.doi_title .input2data-v-74a6fc2e,#header>.doi_title_p>.doi_title .input3data-v-74a6fc2e,#header>.doi_title_p>.doi_title .input4data-v-74a6fc2e{display:inline-flex;align-self:center;line-height:100%;height:36px;width:400px;text-align:left;box-sizing:border-box;padding-left:12px;margin-right:10px}#header>.doi_title_p>.doi_title .input1 inputdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input1 selectdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input2 inputdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input2 selectdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input3 inputdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input3 selectdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input4 inputdata-v-74a6fc2e,#header>.doi_title_p>.doi_title .input4 selectdata-v-74a6fc2e{height:36px;width:100%;padding-left:5px}#header>.doi_title_p>.doi_title .input3data-v-74a6fc2e{width:200px;margin-left:40px}#header>.doi_title_p>.doi_title .input4data-v-74a6fc2e{width:810px}#header>.doi_title_p>.doi_title svgdata-v-74a6fc2e{display:inline-block;width:26px;height:26px;padding-left:5px;cursor:pointer;align-self:center}#header>.doi_title_p>.doi_title svgdata-v-74a6fc2e:last-child{width:12px;margin:0;padding:0}#header>.doi_title_p>.doi_title adata-v-74a6fc2e{display:inline-flex;color:#fff;width:65px;align-self:center;margin-left:15px}#header>.menus_pdata-v-74a6fc2e{background:#5055a6}#header>.menus_p>.menusdata-v-74a6fc2e{width:1200px;margin:0 auto;color:#fff;height:40px;line-height:40px;border-bottom-left-radius:6px;border-bottom-right-radius:6px}#header>.menus_p>.menus>uldata-v-74a6fc2e{display:flex}#header>.menus_p>.menus>ul lidata-v-74a6fc2e{padding:0 15px;display:flex;align-items:center;cursor:pointer;position:relative}#header>.menus_p>.menus>ul li svgdata-v-74a6fc2e{display:block;width:12px;margin-left:8px}#header>.menus_p>.menus>ul li .second-menusdata-v-74a6fc2e{overflow:hidden;position:absolute;z-index:999;width:230px;top:40px;left:0;background:#5055a6}#header>.menus_p>.menus>ul li .second-menus lidata-v-74a6fc2e{height:0;transition:all .3s}#header>.menus_p>.menus>ul li .second-menus li>adata-v-74a6fc2e{width:100%}#header>.menus_p>.menus>ul lidata-v-74a6fc2e:hover{background:#2a34cc}#header>.menus_p>.menus>ul li:hover .second-menus lidata-v-74a6fc2e{height:40px}#header>.search-content_p>.search-contentdata-v-74a6fc2e{height:0;width:1200px;margin:0 auto;overflow:hidden;transition:all .3s;padding:0}#header>.search-content_p>.search-content>divdata-v-74a6fc2e{display:flex}#header>.search-content_p>.search-content>div pdata-v-74a6fc2e{line-height:12px;margin-bottom:6px}#header>.search-content_p>.search-content>div .search-itemdata-v-74a6fc2e{margin-right:20px}#header>.search-content_p>.search-content>div .search-item inputdata-v-74a6fc2e,#header>.search-content_p>.search-content>div .search-item selectdata-v-74a6fc2e{border:1px solid #b7b7b7;border-radius:4px;height:30px;line-height:30px;width:240px;padding:0 12px;box-sizing:border-box}#header>.search-content_p>.search-content>div .search-item .search-btndata-v-74a6fc2e{background:#5297cc;line-height:30px;width:80px;color:#fff;border-radius:4px;text-align:center;margin-top:18px;cursor:pointer}#header>.search-content_p>.search-content>divdata-v-74a6fc2e:first-child{margin-bottom:20px}.bri-bannerdata-v-79275638{width:454px;height:260px;overflow:hidden;position:relative}.bri-banner .bri-banner-contentdata-v-79275638{display:inline-flex;transition:all .5s}.bri-banner .bri-banner-content .bri-banner-itemdata-v-79275638{width:454px;height:260px;position:relative}.bri-banner .bri-banner-content .bri-banner-item imgdata-v-79275638{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}.bri-banner .bri-banner-content .bri-banner-item .bri-banner-remarkdata-v-79275638{position:absolute;bottom:0;background:rgba(0,0,0,.3);color:#fff;padding:10px;width:100%;box-sizing:border-box;height:80px;text-align:center}.bri-banner .bri-banner-content .bri-banner-item .bri-banner-remark>divdata-v-79275638{overflow:hidden;text-overflow:ellipsis;display:-webkit-box;-webkit-box-orient:vertical;-webkit-line-clamp:3}.bri-banner .bri-banner-nodedata-v-79275638{position:absolute;bottom:10px;display:flex;width:100%;justify-content:center}.bri-banner .bri-banner-node>divdata-v-79275638{height:4px;width:16px;border-radius:2px;background:#fff;opacity:.6;margin-right:10px;cursor:pointer;transition:all .3s}.bri-banner .bri-banner-node .activedata-v-79275638{opacity:1;width:48px}.scrollBlockdata-v-ad5e669c{position:relative}.scrollBlock .scrollContentdata-v-ad5e669c{overflow:hidden;width:100%;box-sizing:border-box}.scrollBlock .scrollContent .scroll-warpdata-v-ad5e669c{display:flex;transition:margin .5s}.scrollBlock .scrollContent .scroll-warp>divdata-v-ad5e669c{flex:1}.scrollBlock .changeScrolldata-v-ad5e669c{display:flex;position:absolute;right:0;top:-36px;align-items:center}.scrollBlock .changeScroll svgdata-v-ad5e669c{line-height:20px;vertical-align:middle;display:inline-block;margin:0 8px;cursor:pointer}.scrollBlock .changeScroll adata-v-ad5e669c{vertical-align:middle;line-height:20px;display:inline-block;color:#5297cc;font-weight:700}#articleItemdata-v-608cec44{padding:20px 0;border-bottom:1px solid #d6d6d6}#articleItem>spandata-v-608cec44{color:#dc6835;border:1px solid #dc6835;border-radius:4px;line-height:24px;padding:0 8px}#articleItem .openAccessdata-v-608cec44{color:#dc6835;border:1px solid #dc6835}#articleItem .specialdata-v-608cec44{color:#6d70c6;border:1px solid #6d70c6}#articleItem .retractiondata-v-608cec44{color:#39bf93;border:1px solid #39bf93}#articleItem h4data-v-608cec44{margin:8px 0}#articleItem .authordata-v-608cec44{color:#878787;font-size:12px}#articleItem pdata-v-608cec44{line-height:24px;margin:8px 0}#articleItem .abs-a adata-v-608cec44{color:#5297cc}#articleItemdata-v-608cec44:last-child{border:none}#articleItem .title{color:#5297cc!important}#articleItem .title h1,#articleItem .title p{font-size:14px;line-height:24px;color:#5297cc!important}#articleItem .title h1 span,#articleItem .title p span{color:#5297cc!important}#articleItem:hover{background-color:#ebf0f4}#submitdata-v-5026769f{background:#fff;padding:30px 20px 20px}#submit .imgdata-v-5026769f{width:100%;height:300px;margin:0 auto;position:relative}#submit .img imgdata-v-5026769f{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}#submit .img divdata-v-5026769f{position:absolute;right:-24px;top:-30px;width:76px;height:100px;background:#5297cc;border-radius:6px 0 0 6px;color:#fff;display:flex;justify-content:center;align-items:center;flex-direction:column;font-family:Book Antiqua}#submit .img div spandata-v-5026769f{font-size:16px}#submit .img div .countdata-v-5026769f{font-size:20px}#submit .img divdata-v-5026769f:before{top:0;border-color:#fff #fff transparent transparent}#submit .img divdata-v-5026769f:after,#submit .img divdata-v-5026769f:before{content:;height:0;width:0;position:absolute;right:0;border-style:solid;border-width:12px}#submit .img divdata-v-5026769f:after{bottom:-24px;border-color:#427aa5 transparent transparent #427aa5}#submit .detaildata-v-5026769f{margin-top:10px;line-height:30px}#submit .detail spandata-v-5026769f{font-size:14px;font-weight:700}#submit .detail pdata-v-5026769f{font-size:12px}#submit .detail adata-v-5026769f{font-size:14px;font-weight:700;color:#5297cc}#submit .sub-btnsdata-v-5026769f{width:220px;margin:20px auto 10px}#submit .sub-btns adata-v-5026769f{display:block;line-height:46px;border:1px solid #5055a6;color:#5055a6;border-radius:6px;font-size:18px;text-align:center;margin-bottom:20px;transition:color .5s}#submit .sub-btns adata-v-5026769f:last-child{margin-bottom:10px}#submit .sub-btns a.activedata-v-5026769f{background:#5055a6;color:#fff}#rightDatadata-v-0e8e75e1{padding:20px;background:#fff;margin:16px 0}#rightData div pdata-v-0e8e75e1{font-size:12px;line-height:20px}#rightData div .p-nodedata-v-0e8e75e1{position:relative;padding-left:14px}#rightData div .p-node spandata-v-0e8e75e1{display:none;font-size:12px}#rightData div .p-node:hover spandata-v-0e8e75e1{display:block;margin-left:-14px;background:#f2f2f2;padding:5px 10px}#rightData div .p-nodedata-v-0e8e75e1:after{content:;position:absolute;height:4px;width:4px;left:0;top:10px;background:#5297cc;border-radius:4px}#rightData{padding:20px;background:#fff;margin:16px 0}#rightData .show-page p{font-size:12px;line-height:20px}#rightDatadata-v-a05f0dc6{padding:20px;background:#fff;margin:16px 0}#rightData ul lidata-v-a05f0dc6{padding:20px 0;border-bottom:1px solid #d6d6d6}#rightData ul li spandata-v-a05f0dc6{display:block;font-size:12px;margin-bottom:20px;line-height:10px}#rightData ul li h4data-v-a05f0dc6{font-weight:400;font-size:12px}#rightData ul lidata-v-a05f0dc6:last-child{border:none}#rightData ul lidata-v-a05f0dc6:first-child{padding-top:0}#rightData .show-html{margin-top:8px;font-size:12px;line-height:20px}#rightData .show-html p{font-size:12px}#Impact{background:#fff;text-align:center}#Impact img{width:100%;-o-object-fit:contain;object-fit:contain}#Impact strong{display:block;margin-top:-10px;padding-bottom:20px}#meetingdata-v-b34ac994{margin-top:16px;padding:20px;background:#fff}#meeting .warpdata-v-b34ac994{overflow:hidden}#meeting .warp .scroll-pagedata-v-b34ac994{transition:all .3s;display:flex}#meeting .warp .scroll-page divdata-v-b34ac994{width:220px;margin-right:20px}#meeting imgdata-v-b34ac994{width:220px;height:120px;border-radius:4px;-o-object-fit:cover;object-fit:cover}#meeting ul lidata-v-b34ac994{padding:20px 0;border-bottom:1px solid #d6d6d6}#meeting ul li pdata-v-b34ac994{font-size:12px;line-height:10px;padding:20px 0}#meeting ul li h4data-v-b34ac994{font-weight:700;color:#5297cc}#meeting ul lidata-v-b34ac994:first-child{padding-top:0}#meeting ul lidata-v-b34ac994:last-child{border:none}#meeting .asidedata-v-b34ac994{width:260px;height:460px}.tweets-follow_wrapdata-v-748f833a{margin:16px auto;position:relative}.tweets-follow_wrap .twitter-follow-buttondata-v-748f833a{position:absolute!important;top:13px!important;right:35px!important}#footerdata-v-6d6eb592{background:#5055a6;color:#fff;padding:20px 20px 0;margin:16px auto;width:75rem;min-width:100%}#footer .menusdata-v-6d6eb592{display:flex;padding-bottom:20px;width:75rem;margin:0 auto}#footer .menus uldata-v-6d6eb592{width:25%;padding-left:40px}#footer .menus ul h5data-v-6d6eb592{font-size:18px;font-weight:700;padding:10px 0}#footer .menus ul lidata-v-6d6eb592{font-size:14px;padding:10px 0}#footer .menus ul li adata-v-6d6eb592{display:inline-block}#footer .menus ul li adata-v-6d6eb592:hover{text-decoration:underline}#footer .menus ul .svglidata-v-6d6eb592{font-size:0}#footer .menus ul .svgli svgdata-v-6d6eb592{width:36px;height:36px;margin-right:20px}#footer .bottomdata-v-6d6eb592{line-height:75px;border-top:1px solid #fff;text-align:center;font-size:16px;width:75rem;margin:0 auto}/style>  /head>  body >    div data-server-renderedtrue id__nuxt>!---->div id__layout>div>div idhomepage classcontainer data-v-c17c85d0>header idheader data-v-74a6fc2e data-v-c17c85d0>div classtop data-v-74a6fc2e>div classlogo data-v-74a6fc2e>a href/ data-v-74a6fc2e>img src/_nuxt/img/cf1a3d6.png width50px height50px data-v-74a6fc2e>/a>/div> div classsite-title data-v-74a6fc2e>a href/ data-v-74a6fc2e>MRE Press/a>/div> div classsearch data-v-74a6fc2e>nav classmenus2 data-v-74a6fc2e>ul data-v-74a6fc2e>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/ target_blank data-v-74a6fc2e>Home/a> !---->/li>li classjournals-menu-item data-v-74a6fc2e>a data-v-74a6fc2e>Journals/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a hrefhttps://www.ejgo.net target_blank data-v-74a6fc2e>European Journal of Gynaecological Oncology/a>/li>li data-v-74a6fc2e>a hrefhttps://www.jocpd.com target_blank data-v-74a6fc2e>Journal of Clinical Pediatric Dentistry/a>/li>li data-v-74a6fc2e>a hrefhttps://www.jomh.org/ target_blank data-v-74a6fc2e>Journal of Mens Health/a>/li>li data-v-74a6fc2e>a hrefhttps://www.jofph.com/ target_blank data-v-74a6fc2e>Journal of Oral & Facial Pain and Headache/a>/li>li data-v-74a6fc2e>a hrefhttps://www.intandro.com/ target_blank data-v-74a6fc2e>Revista Internacional de Andrología/a>/li>li data-v-74a6fc2e>a hrefhttps://www.signavitae.com/ target_blank data-v-74a6fc2e>Signa Vitae/a>/li>/ul>/li>li data-v-74a6fc2e>a data-v-74a6fc2e>About/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/about/ target_blank data-v-74a6fc2e>Overview/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/management-team/ target_blank data-v-74a6fc2e>Management Team/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/contact/ target_blank data-v-74a6fc2e>Contact/a>/li>/ul>/li>li data-v-74a6fc2e>a data-v-74a6fc2e>Resources/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/for-authors/ target_blank data-v-74a6fc2e>For Authors/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/for-reviewers/ target_blank data-v-74a6fc2e>For Reviewers/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/for-editors/ target_blank data-v-74a6fc2e>For Editors/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/article-processing-charges/ target_blank data-v-74a6fc2e>Article Processing Charges/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/open-access/ target_blank data-v-74a6fc2e>Open Access/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/editorial-policies/ target_blank data-v-74a6fc2e>Editorial policies/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/publishing-ethic/ target_blank data-v-74a6fc2e>Publishing Ethic/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/copyright-license/ target_blank data-v-74a6fc2e>Copyright & License/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/digital-archive/ target_blank data-v-74a6fc2e>Digital Archive/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/privacy-policy/ target_blank data-v-74a6fc2e>Privacy Policy/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/advertising-policy/ target_blank data-v-74a6fc2e>Advertising policy/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/peer-review-policy/ target_blank data-v-74a6fc2e>Peer Review Policy/a>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/resources/special-issues-supplements-policy/ target_blank data-v-74a6fc2e>Special Issues & Supplements Policy/a>/li>/ul>/li>li data-v-74a6fc2e>a hrefhttps://www.mrepress.net/all-news/ target_blank data-v-74a6fc2e>News/a> !---->/li>/ul>/nav>/div>/div> div classmenus_p data-v-74a6fc2e>nav classmenus data-v-74a6fc2e>ul data-v-74a6fc2e>li data-v-74a6fc2e>a href/ data-v-74a6fc2e>Home/a> !----> !---->/li>li data-v-74a6fc2e>a href/journal-info/overview data-v-74a6fc2e>Journal Info/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a href/journal-info/overview data-v-74a6fc2e>Overview/a>/li>li data-v-74a6fc2e>a href/journal-info/aim-scope data-v-74a6fc2e>Aims & Scope/a>/li>li data-v-74a6fc2e>a href/journal-info/editorial-board data-v-74a6fc2e>Editorial Board/a>/li>li data-v-74a6fc2e>a href/journal-info/indexing-archiving data-v-74a6fc2e>Indexing & Archiving/a>/li>li data-v-74a6fc2e>a href/journal-info/join data-v-74a6fc2e>Join Editorial Board/a>/li>/ul>/li>li data-v-74a6fc2e>a href/special-issues data-v-74a6fc2e>Special Issues/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a href/special-issues data-v-74a6fc2e>Special Issues/a>/li>li data-v-74a6fc2e>a href/special-issues/edit data-v-74a6fc2e>Edit a Special Issue/a>/li>/ul>/li>li data-v-74a6fc2e>a href/articles/current-issue data-v-74a6fc2e>Articles/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a href/articles/current-issue data-v-74a6fc2e>Current Issue/a>/li>li data-v-74a6fc2e>a href/articles/archive data-v-74a6fc2e>Archive/a>/li>/ul>/li>li data-v-74a6fc2e>a href/preprints data-v-74a6fc2e>Published Ahead of Print /a> !----> !---->/li>li data-v-74a6fc2e>a href/for-authors/author-instructions/editorial-policies data-v-74a6fc2e>For Authors/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg> ul classsecond-menus data-v-74a6fc2e>li data-v-74a6fc2e>a hrefhttps://js.ejgo.net data-v-74a6fc2e>Submit/a>/li>li data-v-74a6fc2e>a href/for-authors/instructions-for-authors data-v-74a6fc2e>Instructions for Authors/a>/li>li data-v-74a6fc2e>a href/for-authors/article-processing-charge data-v-74a6fc2e>Article Processing Charge/a>/li>li data-v-74a6fc2e>a href/for-authors/editorial-process data-v-74a6fc2e>Editorial Process/a>/li>/ul>/li>li data-v-74a6fc2e>a href/contact data-v-74a6fc2e>Contact Us/a> !----> !---->/li>/ul>/nav>/div> div classdoi_title_p data-v-74a6fc2e>div classdoi_title data-v-74a6fc2e>div classinput3 data-v-74a6fc2e>select data-v-74a6fc2e>option value0 selectedselected data-v-74a6fc2e>Article/option> option value1 data-v-74a6fc2e>Sepcial Issue/option>/select>/div> div classinput1 styledisplay:; data-v-74a6fc2e>input typetext placeholderEnter Article Title | Key Words | Doi value data-v-74a6fc2e>/div> div classinput2 styledisplay:; data-v-74a6fc2e>input typetext placeholderEnter Authors | Affication value data-v-74a6fc2e>/div> div classinput4 styledisplay:none; data-v-74a6fc2e>input typetext placeholderEnter article title | Keywords value data-v-74a6fc2e>/div> svg t1585820076273 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id1274 width48 height48 classicon data-v-74a6fc2e>path dM979.2 971.2L752 734.4c-68.8 75.2-168 116.8-268.8 120-214.4 3.2-392-177.6-392-398.4 0-217.6 174.4-395.2 385.6-395.2s385.6 177.6 385.6 398.4c0 68.8-19.2 139.2-51.2 198.4-6.4 9.6-3.2 22.4 3.2 32 12.8 12.8 32 9.6 41.6-6.4 38.4-65.6 60.8-142.4 60.8-227.2C916.8 206.4 720 3.2 480 3.2 233.6 6.4 38.4 209.6 38.4 459.2s195.2 451.2 435.2 451.2c97.6 0 195.2-35.2 272-97.6l192 198.4c9.6 9.6 25.6 9.6 38.4 0 12.8-12.8 12.8-27.2 3.2-40z m-761.6-544c16-126.4 113.6-227.2 240-236.8 12.8 0 25.6-12.8 25.6-28.8s-12.8-28.8-25.6-28.8h-3.2c-148.8 12.8-268.8 132.8-288 284.8-3.2 16 9.6 28.8 22.4 32h3.2c12.8 0 22.4-9.6 25.6-22.4z fill#878787 p-id1275 data-v-74a6fc2e>/path>/svg> a classbe-red data-v-74a6fc2e>Advanced/a> svg t1585821628953 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2112 width32 height32 classicon data-v-74a6fc2e>path dM937.003624 288.313451c-6.182816 0-11.775184 2.512217-15.814174 6.554276l-409.18945 387.648854-409.18945-387.648854c-4.040013-4.042059-9.632381-6.554276-15.814174-6.554276-12.363585 0-22.36845 10.005888-22.36845 22.36845 0 6.182816 2.489704 11.775184 6.554276 15.814174l425.003624 402.635173c4.03899 4.064572 9.631358 6.554276 15.814174 6.554276 6.182816 0 11.774161-2.489704 15.814174-6.554276l425.003624-402.635173c4.064572-4.040013 6.554276-9.632381 6.554276-15.814174C959.372074 298.319339 949.367209 288.313451 937.003624 288.313451 p-id2113 fill#ffffff data-v-74a6fc2e>/path>/svg>/div>/div> div classsearch-content_p data-v-74a6fc2e>div classsearch-content data-v-74a6fc2e>div data-v-74a6fc2e>div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Title/p> input typetext placeholderTitle / Keywords value data-v-74a6fc2e>/div> div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Author/p> input typetext placeholderAuthor / affiliation value data-v-74a6fc2e>/div> div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>DOI/p> input typetext placeholderDOI value data-v-74a6fc2e>/div> div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Article Type/p> select placeholderIssue data-v-74a6fc2e>option value data-v-74a6fc2e>ALL/option> /select>/div>/div> div data-v-74a6fc2e>div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Special Issue/p> select placeholderIssue data-v-74a6fc2e>option value data-v-74a6fc2e>ALL/option> /select>/div> div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Volume/p> select placeholderIssue data-v-74a6fc2e>option value data-v-74a6fc2e>ALL/option> /select>/div> div classsearch-item data-v-74a6fc2e>p data-v-74a6fc2e>Issue/p> select placeholderIssue data-v-74a6fc2e>option value data-v-74a6fc2e>ALL/option> /select>/div> div classsearch-item data-v-74a6fc2e>div classsearch-btn data-v-74a6fc2e>Search/div>/div>/div>/div>/div>/header> div classcontent stylemargin-top: 16px data-v-c17c85d0>div classmain data-v-c17c85d0>div classblock data-v-c17c85d0>div data-v-c17c85d0>h2>font faceGeorgia size5>European Journal of Gynaecological Oncology/font>/h2>p>b style>font size1>Print ISSN: 0392-2936 | Online ISSN: 2709-0086/font>/b>/p>p>em>European Journal of Gynaecological Oncology/em> (em>EJGO/em>) is an international, peer-reviewed, open access journal. em>EJGO/em> publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.br>/p>p>br>/p>/div>/div> div classmiddle-content data-v-c17c85d0>div data-v-c17c85d0>div classhotNews data-v-c17c85d0>div classbri-banner data-v-79275638 data-v-c17c85d0>div classbri-banner-content stylemargin-left:-0px; data-v-79275638>div classbri-banner-item border-radius data-v-79275638>a target_blank hrefhttps://cobrca.org/ data-v-79275638>img alt classborder-radius data-v-79275638> div classbri-banner-remark border-radius bri-p data-v-79275638>div data-v-79275638>9th World Congress on Controversies in Breast Cancer (CoBrCa) /div>/div>/a>/div>/div> div classbri-banner-node data-v-79275638>div classactive data-v-79275638>/div>/div>/div>/div> div classblock mar-16 data-v-c17c85d0>h2 data-v-c17c85d0>Articles/h2> div styleposition: relative; margin-top: 40px data-v-c17c85d0>div classbtns data-v-c17c85d0>a classactive data-v-c17c85d0>Latest Articles/a> a data-v-c17c85d0>Most Read/a>/div>/div> div classscrollBlock data-v-ad5e669c data-v-c17c85d0>div idscrollBlock46a72eeb632cd1aa2089d8734621229f classscrollContent data-v-ad5e669c>div idscroll-warp46a72eeb632cd1aa2089d8734621229f classscroll-warp stylewidth:0px;margin-left:-0px; data-v-ad5e669c>div data-v-ad5e669c data-v-c17c85d0>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.090 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Prophylactic HPV vaccines reduce recurrence rates after conization of CIN: a clinical research review/p>/div>/a>/h4> p classauthor data-v-608cec44>Xiu Li,Qingling Ren/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.090/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.090 data-v-608cec44>Abstract ( 852 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2077/pdf/EJGO2024111902.pdf target_blank data-v-608cec44>PDF (331.85 kB) ( 130 ) /a> a href/articles/10.22514/ejgo.2025.090/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.091 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>A United Kingdom national survey of pre-operative imaging and lymph node staging practices in early-stage endometrioid endometrial carcinoma/p>/div>/a>/h4> p classauthor data-v-608cec44>Hannah Pierce,Alison Montgomery,Claire Newton/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.091/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.091 data-v-608cec44>Abstract ( 576 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2078/pdf/EJGO2024121801.pdf target_blank data-v-608cec44>PDF (5.17 MB) ( 141 ) /a> a href/articles/10.22514/ejgo.2025.091/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> span classspecial data-v-608cec44>Special Issue/span> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.092 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Patients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs/p>/div>/a>/h4> p classauthor data-v-608cec44>Jaclyn A. Wall,Tamara Nix-Parker,Marie Bakitas/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.092/p> p styleline-height: 24px data-v-608cec44>    (This article belongs to the Special Issue a href/special-issues/1839562836388265984 stylecolor: #5297cc data-v-608cec44>Quality of Life in Gynecologic Malignancies /a>)  /p> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.092 data-v-608cec44>Abstract ( 561 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2079/pdf/EJGO2024121101.pdf target_blank data-v-608cec44>PDF (1.62 MB) ( 156 ) /a> a href/articles/10.22514/ejgo.2025.092/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.093 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Comparing survivals according to different adjuvant treatments in high-risk endometrial carcinoma: an international and propensity score matching study/p>/div>/a>/h4> p classauthor data-v-608cec44>Joon Young Hong,Yen-Ling Lai,Jung Chen,Tyan-Shin Yang,Yu-Li Chen,Yoo-Young Lee/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.093/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.093 data-v-608cec44>Abstract ( 511 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2080/pdf/EJGO2025020201.pdf target_blank data-v-608cec44>PDF (3.22 MB) ( 121 ) /a> a href/articles/10.22514/ejgo.2025.093/htm data-v-608cec44>Full Text/a>/p>/div>/div>div data-v-ad5e669c data-v-c17c85d0>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2024.110 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Expression and clinical significance of CSAD in type I endometrial carcinoma/p>/div>/a>/h4> p classauthor data-v-608cec44>Hao Huang,Mengni Wang,Xiaojing Chen,Qin Chen,Yan Feng,Baohua Li/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2024.110/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2024.110 data-v-608cec44>Abstract ( 2260 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2091/pdf/EJGO2024071602.pdf target_blank data-v-608cec44>PDF (21.78 MB) ( 194 ) /a> a href/articles/10.22514/ejgo.2024.110/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.094 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Clinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study/p>/div>/a>/h4> p classauthor data-v-608cec44>Akbar Ibrahimov,Gunel Ziyadova,Mehmet Coskun Salman/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.094/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.094 data-v-608cec44>Abstract ( 584 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2081/pdf/EJGO2024122202.pdf target_blank data-v-608cec44>PDF (1.16 MB) ( 136 ) /a> a href/articles/10.22514/ejgo.2025.094/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.095 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Identification of a novel targeting peptide for cervical clear cell adenocarcinoma by i>in vivo/i> phage display screening combined with immunofluorescent analysis/p>/div>/a>/h4> p classauthor data-v-608cec44>Juanli Yang,Xiaomin Liu,Xiaojuan He,Zheng Tang/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.095/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.095 data-v-608cec44>Abstract ( 523 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2082/pdf/EJGO2023113001.pdf target_blank data-v-608cec44>PDF (27.26 MB) ( 110 ) /a> a href/articles/10.22514/ejgo.2025.095/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.096 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>The incidence and clinical outcomes following prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: a single-center retrospective study/p>/div>/a>/h4> p classauthor data-v-608cec44>Tuğçe Sırma,Konul Mehdiyeva,Lena Türeyici,Gürdeniz Serin,Göktuğ Aydoğan,Aslı Ece Solmaz,Haluk Akın,Ahmet Aydın Özsaran,Mustafa Coşan Terek,Levent Akman,Nuri Yıldırım/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.096/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.096 data-v-608cec44>Abstract ( 637 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2083/pdf/EJGO2024123102.pdf target_blank data-v-608cec44>PDF (329.48 kB) ( 180 ) /a> a href/articles/10.22514/ejgo.2025.096/htm data-v-608cec44>Full Text/a>/p>/div>/div>div data-v-ad5e669c data-v-c17c85d0>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.097 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Establishment of a predictive survival prognosis model for epithelial ovarian cancer: a study based on the SEER database/p>/div>/a>/h4> p classauthor data-v-608cec44>Xiaoli Yu,Ying Fan,Ying Liu/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.097/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.097 data-v-608cec44>Abstract ( 588 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2084/pdf/EJGO2024122301.pdf target_blank data-v-608cec44>PDF (2.31 MB) ( 150 ) /a> a href/articles/10.22514/ejgo.2025.097/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.098 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Awareness, attitudes and vaccination intentions regarding cervical cancer and HPV among healthcare workers/p>/div>/a>/h4> p classauthor data-v-608cec44>Yıldız Büyükdereli Atadağ,Aslıhan Çelik Çoban/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.098/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.098 data-v-608cec44>Abstract ( 608 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250717-2093/pdf/EJGO2024123001.pdf target_blank data-v-608cec44>PDF (315.47 kB) ( 151 ) /a> a href/articles/10.22514/ejgo.2025.098/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.099 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Knockdown of i>PIMREG /i>modulates the Wnt/i>β/i>-catenin pathway to suppress proliferation and stemness in endometrial cancer/p>/div>/a>/h4> p classauthor data-v-608cec44>Zhiqing Hu,Qing Wang,Jinyong Wang,Ronghua Qiu/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.099/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.099 data-v-608cec44>Abstract ( 525 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2086/pdf/EJGO2025052202.pdf target_blank data-v-608cec44>PDF (8.98 MB) ( 147 ) /a> a href/articles/10.22514/ejgo.2025.099/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.100 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis/p>/div>/a>/h4> p classauthor data-v-608cec44>Yuhong Yang,Ting Feng,Nayu Shi,Lin Ma,Honger Xu,Xiaojuan Ke/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.100/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.100 data-v-608cec44>Abstract ( 552 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2087/pdf/EJGO2025060301.pdf target_blank data-v-608cec44>PDF (3.47 MB) ( 116 ) /a> a href/articles/10.22514/ejgo.2025.100/htm data-v-608cec44>Full Text/a>/p>/div>/div>div data-v-ad5e669c data-v-c17c85d0>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.101 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Integrating chemoradiotherapy and nivolumab in advanced cervical cancer: two case reports/p>/div>/a>/h4> p classauthor data-v-608cec44>Garima Tripathi,Daniel W. Qiu,Karen C. Wang,Hsin-Lun Lee,Tungho Wu,Jiantai Timothy Qiu/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.101/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.101 data-v-608cec44>Abstract ( 600 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2088/pdf/EJGO2024101404.pdf target_blank data-v-608cec44>PDF (7.36 MB) ( 143 ) /a> a href/articles/10.22514/ejgo.2025.101/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> span classspecial data-v-608cec44>Special Issue/span> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.102 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>A case series of four patients with recurrent ovarian granulosa cell tumors treated with CDK4/6 inhibitors and estrogen blockade in a pilot study/p>/div>/a>/h4> p classauthor data-v-608cec44>Gabriella A. DiBernardo,Andrea I. Nañez,Erica Manrriquez,Lauryn Ruegg,Steven S. Raman,Gottfried E. Konecny,Olga Olevsky,Puja Venkat,Sanaz Memarzadeh/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.102/p> p styleline-height: 24px data-v-608cec44>    (This article belongs to the Special Issue a href/special-issues/1808737138669174784 stylecolor: #5297cc data-v-608cec44>Advances in Ovarian Cancer Research/a>)  /p> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.102 data-v-608cec44>Abstract ( 572 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2089/pdf/EJGO2025020601.pdf target_blank data-v-608cec44>PDF (9.37 MB) ( 132 ) /a> a href/articles/10.22514/ejgo.2025.102/htm data-v-608cec44>Full Text/a>/p>/div>div idarticleItem classborder-radius data-v-608cec44 data-v-c17c85d0>span classopenAccess data-v-608cec44>Open Access/span> !----> !----> h4 data-v-608cec44>a href/articles/10.22514/ejgo.2025.103 data-v-608cec44>div classtitle ql-snow ql-editor data-v-608cec44>p>Rare presentation of cervical choriocarcinoma with metastasis: a case report/p>/div>/a>/h4> p classauthor data-v-608cec44>Javeria Haider,Humera Mahmood,Muhammad Faheem,Shaista Khurshid,Abdullah/p> !----> p data-v-608cec44>strong data-v-608cec44>DOI: /strong>10.22514/ejgo.2025.103/p> !----> p classabs-a data-v-608cec44>a href/articles/10.22514/ejgo.2025.103 data-v-608cec44>Abstract ( 549 ) /a> a hrefhttps://oss.ejgo.net/files/article/20250715-2092/pdf/EJGO2024102001.pdf target_blank data-v-608cec44>PDF (1.6 MB) ( 120 ) /a> a href/articles/10.22514/ejgo.2025.103/htm data-v-608cec44>Full Text/a>/p>/div>/div>/div>/div> div classchangeScroll data-v-ad5e669c>span classchangeScrollBtn data-v-ad5e669c>svg t1586508567192 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2513 width22 height22 classicon data-v-ad5e669c>path dM125.889175 507.73793c0 230.572376 186.916087 417.488463 417.488463 417.488463s417.488463-186.916087 417.488463-417.488463-186.916087-417.488463-417.488463-417.488463S125.889175 277.165554 125.889175 507.73793zM400.643819 493.024833c0.237407-0.25685 0.473791-0.473791 0.791016-0.751107 0.237407-0.25685 0.434905-0.494257 0.711198-0.77055L656.731312 236.936317c7.730055-7.750521 20.246113-7.731078 27.977191 0 7.750521 7.730055 7.750521 20.22667 0 27.957749L456.123388 493.479181l-6.603395 6.603395c0 0-7.612375 6.248308-0.672312 13.168927 6.940063 6.940063 6.485715 6.485715 6.485715 6.485715l230.780107 230.818993c7.731078 7.710612 7.731078 20.266579-0.019443 27.997658-7.731078 7.731078-20.247136 7.710612-27.997658 0L400.643819 521.041934C392.912741 513.330298 392.912741 500.755911 400.643819 493.024833z p-id2514 fill#C3CCD4 data-v-ad5e669c>/path>/svg>a href/articles/current-issue data-v-ad5e669c>all/a>svg t1586508659926 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id7214 width22 height22 classicon data-v-ad5e669c>path dM512 65C265.1 65 65 265.1 65 512s200.1 447 447 447 447-200.1 447-447S758.9 65 512 65z m146.1 461.1L408.3 776c-7.8 7.8-20.5 7.8-28.3 0-7.8-7.8-7.8-20.5 0-28.3l229.4-229.4c3.5-3.5 3.5-9.2 0-12.7L380 276.3c-7.8-7.8-7.8-20.5 0-28.3 7.8-7.8 20.5-7.8 28.3 0l249.9 249.9c7.7 7.8 7.7 20.4-0.1 28.2z p-id7215 fill#5297CC data-v-ad5e669c>/path>/svg>/span>/div>/div>/div> div classblock mar-16 preprints data-v-c17c85d0>h2 data-v-c17c85d0>Published Ahead of Print/h2> div classscrollBlock data-v-ad5e669c data-v-c17c85d0>div idscrollBlock8a8fe1b648cb991545499f5af0c38a96 classscrollContent data-v-ad5e669c>div idscroll-warp8a8fe1b648cb991545499f5af0c38a96 classscroll-warp stylewidth:0px;margin-left:-0px; data-v-ad5e669c>/div>/div> div classchangeScroll data-v-ad5e669c>span classchangeScrollBtn data-v-ad5e669c>svg t1586508567192 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2513 width22 height22 classicon data-v-ad5e669c>path dM125.889175 507.73793c0 230.572376 186.916087 417.488463 417.488463 417.488463s417.488463-186.916087 417.488463-417.488463-186.916087-417.488463-417.488463-417.488463S125.889175 277.165554 125.889175 507.73793zM400.643819 493.024833c0.237407-0.25685 0.473791-0.473791 0.791016-0.751107 0.237407-0.25685 0.434905-0.494257 0.711198-0.77055L656.731312 236.936317c7.730055-7.750521 20.246113-7.731078 27.977191 0 7.750521 7.730055 7.750521 20.22667 0 27.957749L456.123388 493.479181l-6.603395 6.603395c0 0-7.612375 6.248308-0.672312 13.168927 6.940063 6.940063 6.485715 6.485715 6.485715 6.485715l230.780107 230.818993c7.731078 7.710612 7.731078 20.266579-0.019443 27.997658-7.731078 7.731078-20.247136 7.710612-27.997658 0L400.643819 521.041934C392.912741 513.330298 392.912741 500.755911 400.643819 493.024833z p-id2514 fill#C3CCD4 data-v-ad5e669c>/path>/svg>a href/preprints data-v-ad5e669c>all/a>svg t1586508659926 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id7214 width22 height22 classicon data-v-ad5e669c>path dM512 65C265.1 65 65 265.1 65 512s200.1 447 447 447 447-200.1 447-447S758.9 65 512 65z m146.1 461.1L408.3 776c-7.8 7.8-20.5 7.8-28.3 0-7.8-7.8-7.8-20.5 0-28.3l229.4-229.4c3.5-3.5 3.5-9.2 0-12.7L380 276.3c-7.8-7.8-7.8-20.5 0-28.3 7.8-7.8 20.5-7.8 28.3 0l249.9 249.9c7.7 7.8 7.7 20.4-0.1 28.2z p-id7215 fill#5297CC data-v-ad5e669c>/path>/svg>/span>/div>/div>/div>/div> div data-v-c17c85d0>div classhotNews data-v-c17c85d0>div classbri-banner data-v-79275638 data-v-c17c85d0>div classbri-banner-content stylemargin-left:-0px; data-v-79275638>div classbri-banner-item border-radius data-v-79275638>a target_blank hrefhttps://www.ejgo.net/articles/10.22514/ejgo.2024.022 data-v-79275638>img alt classborder-radius data-v-79275638> div classbri-banner-remark border-radius bri-p data-v-79275638>div data-v-79275638>Hysteroscopic-view of endometrial atypical hyperplasia. A helpful diagnostic tool in the care and treatment process?/div>/div>/a>/div>/div> div classbri-banner-node data-v-79275638>div classactive data-v-79275638>/div>/div>/div>/div> div classblock mar-16 special-issues data-v-c17c85d0>h2 data-v-c17c85d0>Special Issues/h2> div classscrollBlock data-v-ad5e669c data-v-c17c85d0>div idscrollBlock1f65de2d9bbd9a39d53c8348c986396b classscrollContent data-v-ad5e669c>div idscroll-warp1f65de2d9bbd9a39d53c8348c986396b classscroll-warp stylewidth:0px;margin-left:-0px; data-v-ad5e669c>div data-v-ad5e669c data-v-c17c85d0>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1839562836388265984 data-v-ad5e669c data-v-c17c85d0> Quality of Life in Gynecologic Malignancies /a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Quality of life; Palliative care; Symptom management                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Lori  Spoozak, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 December 2024/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1815302495915655168 data-v-ad5e669c data-v-c17c85d0> Endometrial Cancer and Fertility Preservation in the Denatality ERA/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Dr. Giuseppe  Gullo, MD, PhD,Dr. Alessandra  Lopez, MD,Dr. Valentina  Billone, MD, PhD St.                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 December 2025/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1808737138669174784 data-v-ad5e669c data-v-c17c85d0> Advances in Ovarian Cancer Research/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Basel  Refky, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 July 2025/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1729021801237757952 data-v-ad5e669c data-v-c17c85d0> Current Update in the Treatment of Cervical Cancer /a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Radical Hysterectomy; Fertility Sparing; Oncological Outcomes                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Carlo  Ronsini, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 December 2025/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1582537875917815808 data-v-ad5e669c data-v-c17c85d0> Gynecological Cancer Prevention: A New Prospective/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology                   /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Ottavia  Dʼoria, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 October 2023/p>/div>/div>div data-v-ad5e669c data-v-c17c85d0>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1578681106963546112 data-v-ad5e669c data-v-c17c85d0> Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Prof. Takuma  Hayashi                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 October 2023/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1547775802780598272 data-v-ad5e669c data-v-c17c85d0> Molecular Characterization in Endometrial Cancer: Progress and Prospects /a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Andrea  Giannini, MD, PhD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 December 2022/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1518156026391478272 data-v-ad5e669c data-v-c17c85d0> Immunotherapy for Gynecological Oncology/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Tadahiro  Shoji, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 July 2021/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1530003309781237760 data-v-ad5e669c data-v-c17c85d0> Enhanced Recovery of Gynecological Oncology/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Lin  Li, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 31 December 2022/p>/div>div classspecial-issues-item data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Special issue title: /span> h4 data-v-ad5e669c data-v-c17c85d0>a href/special-issues/1518512499617349632 data-v-ad5e669c data-v-c17c85d0> Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy/a>/h4> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498383707 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8044 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM576.224 289.28 818.944 207.84 1022.528 814.624 779.808 896.064zM0 896l256 0L256 192 0 192 0 896zM64 320l128 0 0 64L64 384 64 320zM320 896l256 0L576 192 320 192 320 896zM384 320l128 0 0 64-128 0L384 320z p-id8045 fill#B7B7B7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>                      Keywords:/span>                    Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers                  /p> p data-v-ad5e669c data-v-c17c85d0>span classinline-svg data-v-ad5e669c data-v-c17c85d0>svg t1586498422250 viewBox0 0 1032 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id8814 width14 height14 classicon data-v-ad5e669c data-v-c17c85d0>path dM494.870476 507.635572c160.939766 0 291.404485-111.604041 291.404485-249.237064 0-137.664224-130.464718-249.229265-291.404485-249.229265-160.924166 0-291.412285 111.56504-291.396684 249.229265 0 137.633024 130.472518 249.237065 291.404485 249.237064zM628.455241 590.737994H385.59087c-207.888657 0-376.433535 144.122719-376.433535 321.910733v20.779506c0 72.665868 168.544878 72.736069 376.433535 72.736069H628.455241c207.865256 0 376.402334-2.683239 376.402334-72.736069v-20.771705c0-177.795814-168.521478-321.918533-376.402334-321.918534z p-id8815 fill#b7b7b7 data-v-ad5e669c data-v-c17c85d0>/path>/svg>Editor:/span>                    Sharad  Ghamande, MD,David  Mysona, MD                  /p> p data-v-ad5e669c data-v-c17c85d0>span data-v-ad5e669c data-v-c17c85d0>Submission deadline:/span> 30 March 2022/p>/div>/div>/div>/div> div classchangeScroll data-v-ad5e669c>span classchangeScrollBtn data-v-ad5e669c>svg t1586508567192 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id2513 width22 height22 classicon data-v-ad5e669c>path dM125.889175 507.73793c0 230.572376 186.916087 417.488463 417.488463 417.488463s417.488463-186.916087 417.488463-417.488463-186.916087-417.488463-417.488463-417.488463S125.889175 277.165554 125.889175 507.73793zM400.643819 493.024833c0.237407-0.25685 0.473791-0.473791 0.791016-0.751107 0.237407-0.25685 0.434905-0.494257 0.711198-0.77055L656.731312 236.936317c7.730055-7.750521 20.246113-7.731078 27.977191 0 7.750521 7.730055 7.750521 20.22667 0 27.957749L456.123388 493.479181l-6.603395 6.603395c0 0-7.612375 6.248308-0.672312 13.168927 6.940063 6.940063 6.485715 6.485715 6.485715 6.485715l230.780107 230.818993c7.731078 7.710612 7.731078 20.266579-0.019443 27.997658-7.731078 7.731078-20.247136 7.710612-27.997658 0L400.643819 521.041934C392.912741 513.330298 392.912741 500.755911 400.643819 493.024833z p-id2514 fill#C3CCD4 data-v-ad5e669c>/path>/svg>a href/special-issues data-v-ad5e669c>all/a>svg t1586508659926 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id7214 width22 height22 classicon data-v-ad5e669c>path dM512 65C265.1 65 65 265.1 65 512s200.1 447 447 447 447-200.1 447-447S758.9 65 512 65z m146.1 461.1L408.3 776c-7.8 7.8-20.5 7.8-28.3 0-7.8-7.8-7.8-20.5 0-28.3l229.4-229.4c3.5-3.5 3.5-9.2 0-12.7L380 276.3c-7.8-7.8-7.8-20.5 0-28.3 7.8-7.8 20.5-7.8 28.3 0l249.9 249.9c7.7 7.8 7.7 20.4-0.1 28.2z p-id7215 fill#5297CC data-v-ad5e669c>/path>/svg>/span>/div>/div>/div> div classblock mar-16 tweets data-v-c17c85d0>h2 data-v-c17c85d0>Featured Article/h2> div classql-snow ql-editor data-v-c17c85d0>p>Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States.  DOI: a classbe-blue hrefhttps://www.ejgo.net/articles/10.31083/j.ejgo4206181>10.31083/j.ejgo4206181/a>/p>/div> img alt data-v-c17c85d0>/div> div classblock mar-16 rewiewer data-v-c17c85d0>h2 data-v-c17c85d0>To Be a Reviewer/h2> p classtext-j data-v-c17c85d0>              If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be              automatically added to our database of reviewers.            /p> a hrefhttps://js.ejgo.net/ch/auditor/login.aspx data-v-c17c85d0>Review for EJGO/a>/div> div classblock mar-16 rewiewer join data-v-c17c85d0>h2 data-v-c17c85d0>Join Editorial Board/h2> p classtext-j data-v-c17c85d0>              You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members              of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.            /p> a href/journal-info/join data-v-c17c85d0>Join Editorial Board/a>/div>/div>/div> div classblock data-v-c17c85d0>div data-v-c17c85d0>p>b>Editor-in-Chief/b>/p>p>b>br>/b>/p>p>b>Prof. Enrique Hernandez, MD, FACOG, FACS./b>/p>p>Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools./p>/div>/div>/div> aside classborder-radius data-v-c17c85d0>div idsubmit classborder-radius data-v-5026769f data-v-c17c85d0>div classimg data-v-5026769f>img alt data-v-5026769f>/div> div classdetail data-v-5026769f>span data-v-5026769f>Current Issue/span> p data-v-5026769f>Vol., Issue , Invalid date/p> a href/articles/current-issue data-v-5026769f>Table of contents/a>br data-v-5026769f> a href/articles/archive data-v-5026769f>All Issues/a>/div> div classsub-btns data-v-5026769f>a hrefhttps://js.ejgo.net/ch/author/login.aspx classactive data-v-5026769f>Submit to EJGO/a> a hrefhttps://js.ejgo.net/ch/auditor/login.aspx data-v-5026769f>Review for EJGO/a> a href/special-issues/edit data-v-5026769f>Edit a Special Issue/a>/div>/div> div idrightData classborder-radius data-v-0e8e75e1 data-v-c17c85d0>h2 data-v-0e8e75e1>Abstracted / indexed in/h2> div data-v-0e8e75e1>p classp-node data-v-0e8e75e1> Science Citation Index Expanded (SciSearch)      span data-v-0e8e75e1>Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present./span>/p> p classp-node data-v-0e8e75e1> Biological Abstracts      span data-v-0e8e75e1>Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results./span>/p> p classp-node data-v-0e8e75e1> Google Scholar      span data-v-0e8e75e1>Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines./span>/p> p classp-node data-v-0e8e75e1> JournalSeek      span data-v-0e8e75e1>Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN./span>/p> p classp-node data-v-0e8e75e1> Current Contents - Clinical Medicine      span data-v-0e8e75e1>Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine./span>/p> p classp-node data-v-0e8e75e1> BIOSIS Previews      span data-v-0e8e75e1>BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present./span>/p> p classp-node data-v-0e8e75e1> Journal Citation Reports/Science Edition      span data-v-0e8e75e1>Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal. /span>/p>/div>/div> div idrightData classborder-radius data-v-c17c85d0>h2>Submission Turnaround Time/h2> div classshow-page>/div>/div> div idrightData classborder-radius data-v-a05f0dc6 data-v-c17c85d0>h2 data-v-a05f0dc6>/h2> span data-v-a05f0dc6>/span> div classshow-html data-v-a05f0dc6>/div>/div> div idImpact classborder-radius data-v-c17c85d0>div>img srchttp://oss.ejgo.net/files/static/ejgo-impact-factor.jpg alt classborder-radius> strong>Impact Factor 2024: 0.5/strong>/div>/div> div idmeeting classaside border-radius data-v-b34ac994 data-v-c17c85d0>h2 data-v-b34ac994>Conferences/h2> div classwarp data-v-b34ac994>div classscroll-page stylewidth:0px;margin-left:-0px; data-v-b34ac994>/div>/div>/div> div classtweets-follow_wrap border-radius data-v-748f833a data-v-c17c85d0>a data-height450 hrefhttps://twitter.com/EJGO_1980?ref_srctwsrc%5Etfw classtwitter-timeline data-v-748f833a>/a> div classtwitter-follow-button data-v-748f833a>a data-show-countfalse data-sizedefault data-show-screen-namefalse hrefhttps://twitter.com/EJGO_1980 classtwitter-follow-button follow-button data-v-748f833a>/a>/div>/div>/aside>/div> footer idfooter classbb border-radius data-v-6d6eb592 data-v-c17c85d0>div classmenus data-v-6d6eb592>ul data-v-6d6eb592>h5 data-v-6d6eb592>Services/h5> li data-v-6d6eb592>a href/journal-info/overview target_parent data-v-6d6eb592>Journal/a>/li>li data-v-6d6eb592>a href/special-issues target_parent data-v-6d6eb592>Special Issues/a>/li>li data-v-6d6eb592>a hrefhttps://www.mrepress.net/resources/copyright-license/ target_parent data-v-6d6eb592>Copyright/a>/li>/ul>ul data-v-6d6eb592>h5 data-v-6d6eb592>Articles/h5> li data-v-6d6eb592>a href/articles/current-issue target_parent data-v-6d6eb592>Current Issue/a>/li>li data-v-6d6eb592>a href/articles/archive target_parent data-v-6d6eb592>Archive/a>/li>li data-v-6d6eb592>a href/preprints target_parent data-v-6d6eb592>Published Ahead of Print /a>/li>/ul>ul data-v-6d6eb592>h5 data-v-6d6eb592>About/h5> li data-v-6d6eb592>a href/journal-info/editorial-board target_parent data-v-6d6eb592>Editorial Board/a>/li>li data-v-6d6eb592>a href/contact target_parent data-v-6d6eb592>Contact Us/a>/li>li data-v-6d6eb592>a hrefhttps://www.mrepress.net/resources/open-access/  target_parent data-v-6d6eb592>Open Access/a>/li>/ul> ul data-v-6d6eb592>h5 data-v-6d6eb592>a href/contact target_parent data-v-6d6eb592>Contact Us/a>/h5> li data-v-6d6eb592>a href data-v-6d6eb592>Print ISSN: 0392-2936/a>/li> li data-v-6d6eb592>a href data-v-6d6eb592>Online ISSN: 2709-0086/a>/li> li classsvgli data-v-6d6eb592>a hrefhttps://www.ejgo.net data-v-6d6eb592>svg t1586249738050 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id1335 width64 height64 classicon data-v-6d6eb592>path dM512 0C229.26 0 0 229.26 0 512s229.26 512 512 512 512-229.26 512-512S794.74 0 512 0zM386.86 725.37H283v-335h103.86z m-52.69-374.74a67.83 67.83 0 1 1 3.89-0.69c-1.37 0-2.63-0.11-4-0.23z m431 374.74H661.26v-185c0-42.63-14.86-71.2-52.57-71.2a56.83 56.83 0 0 0-53.15 38.63 68.57 68.57 0 0 0 0 26.4l-0.11 190.74H448.8V390.4h90.29l5 46.17a120.1 120.1 0 0 1 103.32-53.94c71 0 119.31 45.48 119.31 142.17-0.09 0-1.58 200.57-1.58 200.57z p-id1336 fill#ffffff data-v-6d6eb592>/path>/svg>/a> a hrefhttps://www.ejgo.net data-v-6d6eb592>svg t1586249780575 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id1559 width64 height64 classicon data-v-6d6eb592>path dM512 0C229.05 0 0 229.05 0 512s229.05 512 512 512 512-229 512-512S795 0 512 0z m137.4 509.31h-88.89V830h-132V509.31h-67.42V398.85h67.38v-67.38c0-88.89 37.73-142.8 142.8-142.8h88.89v110.47h-53.91c-40.4 0-43.09 16.18-43.09 43.09v53.91h99.68l-13.47 113.18z p-id1560 fill#ffffff data-v-6d6eb592>/path>/svg>/a> a hrefhttps://www.ejgo.net data-v-6d6eb592>svg t1586249801693 viewBox0 0 1024 1024 version1.1 xmlnshttp://www.w3.org/2000/svg p-id1749 width64 height64 classicon data-v-6d6eb592>path dM512 0C229.21 0 0 229.21 0 512s229.21 512 512 512 512-229.21 512-512S794.79 0 512 0z m260.41 413.88c-2.89 218.54-142.66 368.24-351.26 377.65-86 3.93-148.36-23.86-202.61-58.32 63.58 10.15 142.43-15.27 184.6-51.36-62.33-6.08-99.23-37.79-116.5-88.85a145.45 145.45 0 0 0 54.1-1.34c-56.25-18.82-96.41-53.57-98.49-126.42 15.79 7.19 32.24 13.93 54.1 15.26-42.09-23.93-73.22-111.45-37.57-169.33 62.47 68.48 137.61 124.35 261 131.91-31-132.43 144.51-204.24 218-115.23 31-6 56.32-17.79 80.63-30.61-10 30.75-29.28 52.25-52.77 69.44 25.79-3.49 48.62-9.78 68.11-19.42-12.13 25.12-38.59 47.65-61.34 66.62z p-id1750 fill#ffffff data-v-6d6eb592>/path>/svg>/a>/li>/ul>/div> div classbottom data-v-6d6eb592>    Copyright © 2025 MRE PRESS.  /div>/footer>/div>/div>/div>/div>script>window.__NUXT__(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH,aI,aJ,aK,aL,aM,aN,aO,aP,aQ,aR,aS,aT,aU,aV,aW,aX,aY,aZ,a_,a$,ba,bb,bc,bd,be,bf,bg,bh,bi,bj,bk,bl,bm,bn,bo,bp,bq,br,bs,bt,bu,bv,bw,bx,by,bz,bA,bB,bC,bD,bE,bF,bG,bH,bI,bJ,bK,bL,bM,bN,bO,bP,bQ,bR,bS,bT,bU){return {layout:default,data:{path:\u002F,hotNews:{id:1901819347105398784,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fhot_spot\u002F6496 - CoBrCa 2025 440x200.jpg,title:9th World Congress on Controversies in Breast Cancer (CoBrCa) ,linkUrl:https:\u002F\u002Fcobrca.org\u002F,isDeleted:b,createTime:2025-03-18T02:14:01.000+0000,updateTime:2025-03-18T02:19:31.000+0000,isReleased:c,sorted:N,releaseTime:2025-03-18T02:14:15.000+0000},{id:1874633845747138560,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fhot_spot\u002FQQ20250102-094748.png,title:aW,linkUrl:https:\u002F\u002Fwww.ejgo.net\u002Farticles\u002F10.22514\u002Fejgo.2024.022,isDeleted:b,createTime:2025-01-02T01:48:32.000+0000,updateTime:aP,isReleased:c,sorted:b,releaseTime:aP},specialIssues:{id:aI,startTime:2024-09-26T16:00:00.000+0000,endTime:bm,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1839562836388265984\u002Fpropagate\u002FSI flyer-Quality of life in gynecologic malignancies.pdf,keyword:Quality of life; Palliative care; Symptom management,title:aO,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2024-09-27T07:08:52.000+0000,updateTime:2025-08-01T19:19:18.000+0000,source:b,releaseTime:2024-09-27T07:11:57.000+0000,sorted:az,accessCount:1020,propagateDownloadCount:33,guestEditors:a,articleCount:a,editorNames:Lori  Spoozak, MD},{id:1815302495915655168,startTime:2024-07-21T16:00:00.000+0000,endTime:aR,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1815302495915655168\u002Fpropagate\u002FSI flyer-Endometrial cancer and fertility preservation in the denatality ERA.pdf,keyword:Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve,title:Endometrial Cancer and Fertility Preservation in the Denatality ERA,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2024-07-22T08:26:56.000+0000,updateTime:2025-08-01T19:19:16.000+0000,source:b,releaseTime:2024-07-22T08:28:48.000+0000,sorted:ax,accessCount:1432,propagateDownloadCount:au,guestEditors:a,articleCount:a,editorNames:Dr. Giuseppe  Gullo, MD, PhD,Dr. Alessandra  Lopez, MD,Dr. Valentina  Billone, MD, PhD St.},{id:aS,startTime:2024-07-03T16:00:00.000+0000,endTime:2025-07-30T16:00:00.000+0000,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1808737138669174784\u002Fpropagate\u002Fflyer.pdf,keyword:Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation,title:aU,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2024-07-04T05:38:33.000+0000,updateTime:2025-08-01T19:19:15.000+0000,source:b,releaseTime:2024-07-04T05:52:11.000+0000,sorted:V,accessCount:2858,propagateDownloadCount:28,guestEditors:a,articleCount:a,editorNames:Basel  Refky, MD},{id:1729021801237757952,startTime:2023-11-26T16:00:00.000+0000,endTime:aR,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1729021801237757952\u002Fpropagate\u002Fflyer 2025.pdf,keyword:Radical Hysterectomy; Fertility Sparing; Oncological Outcomes,title:Current Update in the Treatment of Cervical Cancer ,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2023-11-27T06:18:15.000+0000,updateTime:2025-08-01T19:19:14.000+0000,source:b,releaseTime:2025-05-29T09:26:01.000+0000,sorted:an,accessCount:3725,propagateDownloadCount:43,guestEditors:a,articleCount:a,editorNames:Carlo  Ronsini, MD},{id:1582537875917815808,startTime:2022-10-18T16:00:00.000+0000,endTime:aY,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1582537875917815808\u002Fpropagate\u002Fflyer.pdf,keyword:Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology ,title:Gynecological Cancer Prevention: A New Prospective,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-10-19T01:03:26.000+0000,updateTime:2025-08-01T19:19:12.000+0000,source:b,releaseTime:2022-10-19T01:04:32.000+0000,sorted:N,accessCount:4099,propagateDownloadCount:aZ,guestEditors:a,articleCount:a,editorNames:Ottavia  Dʼoria, MD},{id:1578681106963546112,startTime:ba,endTime:aY,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1578681106963546112\u002Fpropagate\u002Fflyer-final.pdf,keyword:Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer,title:Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods\r\n,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-10-08T09:38:01.000+0000,updateTime:2025-08-01T19:19:11.000+0000,source:b,releaseTime:2022-10-08T09:43:46.000+0000,sorted:c,accessCount:3822,propagateDownloadCount:bf,guestEditors:a,articleCount:a,editorNames:Prof. Takuma  Hayashi},{id:1547775802780598272,startTime:2022-07-14T16:00:00.000+0000,endTime:aG,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1547775802780598272\u002Fpropagate\u002FMolecular characterization in endometrial cancer progress andprospects.pdf,keyword:Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine,title:Molecular Characterization in Endometrial Cancer: Progress and Prospects ,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-07-15T02:51:22.000+0000,updateTime:2025-08-01T19:19:10.000+0000,source:b,releaseTime:2022-09-21T03:18:16.000+0000,sorted:b,accessCount:3475,propagateDownloadCount:aC,guestEditors:a,articleCount:a,editorNames:Andrea  Giannini, MD, PhD},{id:1518156026391478272,startTime:2020-07-31T16:00:00.000+0000,endTime:2021-07-30T16:00:00.000+0000,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1518156026391478272\u002Fpropagate\u002FImmunotherapy for Gynecological Oncology.pdf,keyword:Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer,title:Immunotherapy for Gynecological Oncology,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-04-24T09:12:57.000+0000,updateTime:2025-08-01T19:19:07.000+0000,source:b,releaseTime:2022-08-03T08:35:42.000+0000,sorted:b,accessCount:2779,propagateDownloadCount:V,guestEditors:a,articleCount:a,editorNames:Tadahiro  Shoji, MD},{id:1530003309781237760,startTime:2022-05-26T16:00:00.000+0000,endTime:aG,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1530003309781237760\u002Fpropagate\u002FEnhanced Recovery of Gynecological Oncology-flyer.pdf,keyword:Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management,title:Enhanced Recovery of Gynecological Oncology,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-05-27T01:49:49.000+0000,updateTime:2025-08-01T19:19:09.000+0000,source:b,releaseTime:2022-05-27T01:52:35.000+0000,sorted:b,accessCount:3700,propagateDownloadCount:22,guestEditors:a,articleCount:a,editorNames:Lin  Li, MD},{id:1518512499617349632,startTime:2021-03-30T16:00:00.000+0000,endTime:2022-03-29T16:00:00.000+0000,propagate:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fspecial\u002F1518512499617349632\u002Fpropagate\u002FMolecular Markers in Ovarian Cancer Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy.pdf,keyword:Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers,title:Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy,isReleased:c,introduction:a,section:a,isDeleted:b,createTime:2022-04-25T08:49:27.000+0000,updateTime:2025-08-01T19:19:08.000+0000,source:b,releaseTime:2022-04-25T08:52:25.000+0000,sorted:b,accessCount:2643,propagateDownloadCount:az,guestEditors:a,articleCount:a,editorNames:Sharad  Ghamande, MD,David  Mysona, MD},preprintsList:,newArticleList:{id:1944954452187201536,number:EJGO2024111902,doi:10.22514\u002Fejgo.2025.090,volumeId:g,issueId:l,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:Prophylactic HPV vaccines reduce recurrence rates after conization of CIN: a clinical research review,author:Xiu Li,Qingling Ren,authorMark:{name: Xiu Li,org:1 2 3},{name: Qingling Ren,email:yfy0047@njucm.edu.cn,org:1 2 3 * ,Corresponding:1},submitted:2024-11-18T16:00:00.000+0000,accepted:bT,published:a,releaseTime:k,keyword:Prophylactic HPV vaccine; Conization; CIN; Recurrence; Clinical studies,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2077\u002Fpdf\u002FEJGO2024111902.pdf,onlineTime:a,startPage:c,endPage:D,accessCount:852,downloadPdfCount:130,isDeleted:b,createTime:2025-07-15T02:57:31.000+0000,updateTime:2025-08-01T19:17:39.000+0000,status:b,sorted:M,cancelTime:a,pdfSize:331.85 kB,keywordRich:\u003Cp\u003EProphylactic HPV vaccine; Conization; CIN; Recurrence; Clinical studies\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EProphylactic HPV vaccines reduce recurrence rates after conization of CIN: a clinical research review\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01934-5,academicEditor:a},{id:1944957155541958656,number:EJGO2024121801,doi:10.22514\u002Fejgo.2025.091,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:A United Kingdom national survey of pre-operative imaging and lymph node staging practices in early-stage endometrioid endometrial carcinoma,author:Hannah Pierce,Alison Montgomery,Claire Newton,authorMark:{name: Hannah Pierce,org:1 †},{name: Alison Montgomery,org:1 †},{name: Claire Newton,email:Claire.newton@uhbw.nhs.uk,org:1 2 * ,Corresponding:1},submitted:2024-12-17T16:00:00.000+0000,accepted:2025-01-21T16:00:00.000+0000,published:a,releaseTime:k,keyword:Gynaecological cancer; Endometrial cancer; Pre-operative imaging; Lymph node staging; Molecular classification,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2078\u002Fpdf\u002FEJGO2024121801.pdf,onlineTime:a,startPage:aa,endPage:bR,accessCount:576,downloadPdfCount:bP,isDeleted:b,createTime:2025-07-15T03:08:16.000+0000,updateTime:2025-08-01T19:17:43.000+0000,status:b,sorted:bN,cancelTime:a,pdfSize:5.17 MB,keywordRich:\u003Cp\u003EGynaecological cancer; Endometrial cancer; Pre-operative imaging; Lymph node staging; Molecular classification\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EA United Kingdom national survey of pre-operative imaging and lymph node staging practices in early-stage endometrioid endometrial carcinoma\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01935-7,academicEditor:a},{id:1944959758271168512,number:EJGO2024121101,doi:10.22514\u002Fejgo.2025.092,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:aI,specialTitle:aO,isPreprinted:b,title:Patients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs,author:Jaclyn A. Wall,Tamara Nix-Parker,Marie Bakitas,authorMark:{name: Jaclyn A. Wall,email:jaclyn.wall@vcuhealth.org,org:1 * ,Corresponding:1},{name: Tamara Nix-Parker,org:2},{name: Marie Bakitas,org:2 3 4},submitted:2024-12-10T16:00:00.000+0000,accepted:2025-02-19T16:00:00.000+0000,published:a,releaseTime:k,keyword:Cervical cancer; Palliative care; Mixed methods; Quality of life,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2079\u002Fpdf\u002FEJGO2024121101.pdf,onlineTime:a,startPage:aq,endPage:26,accessCount:561,downloadPdfCount:156,isDeleted:b,createTime:2025-07-15T03:18:36.000+0000,updateTime:2025-08-01T19:34:37.000+0000,status:b,sorted:av,cancelTime:a,pdfSize:1.62 MB,keywordRich:\u003Cp\u003ECervical cancer; Palliative care; Mixed methods; Quality of life\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EPatients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01936-9,academicEditor:a},{id:1944960723317604352,number:EJGO2025020201,doi:10.22514\u002Fejgo.2025.093,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Comparing survivals according to different adjuvant treatments in high-risk endometrial carcinoma: an international and propensity score matching study,author:Joon Young Hong,Yen-Ling Lai,Jung Chen,Tyan-Shin Yang,Yu-Li Chen,Yoo-Young Lee,authorMark:{name: Joon Young Hong,org:1 †},{name: Yen-Ling Lai,org:2 3 4 †},{name: Jung Chen,org:2 3 5},{name: Tyan-Shin Yang,org:3},{name: Yu-Li Chen,email:yulichen1007@ntu.edu.tw,org:2 3 * ,Corresponding:1},{name: Yoo-Young Lee,email:yooyounglee@skku.edu,org:1 * ,Corresponding:1},submitted:2025-02-01T16:00:00.000+0000,accepted:2025-03-23T16:00:00.000+0000,published:a,releaseTime:k,keyword:High-risk endometrial cancer; Adjuvant treatment; Propensity score matching,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2080\u002Fpdf\u002FEJGO2025020201.pdf,onlineTime:a,startPage:27,endPage:36,accessCount:bI,downloadPdfCount:121,isDeleted:b,createTime:2025-07-15T03:22:26.000+0000,updateTime:2025-08-01T19:34:13.000+0000,status:b,sorted:12,cancelTime:a,pdfSize:3.22 MB,keywordRich:\u003Cp\u003EHigh-risk endometrial cancer; Adjuvant treatment; Propensity score matching\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EComparing survivals according to different adjuvant treatments in high-risk endometrial carcinoma: an international and propensity score matching study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01937-0,academicEditor:a},{id:1850827493396627456,number:EJGO2024071602,doi:10.22514\u002Fejgo.2024.110,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Expression and clinical significance of CSAD in type I endometrial carcinoma,author:Hao Huang,Mengni Wang,Xiaojing Chen,Qin Chen,Yan Feng,Baohua Li,authorMark:{name: Hao Huang,org:1 †},{name: Mengni Wang,org:2 †},{name: Xiaojing Chen,org:1},{name: Qin Chen,org:3},{name: Yan Feng,org:2},{name: Baohua Li,email:lbh19787@zju.edu.cn,org:1 2 * ,Corresponding:1},submitted:2024-07-15T16:00:00.000+0000,accepted:2024-08-27T16:00:00.000+0000,published:a,releaseTime:k,keyword:Cysteine sulfinate; Decarboxylase; Type I endometrial carcinoma; Prognosis; Proliferation; Apoptosis,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2091\u002Fpdf\u002FEJGO2024071602.pdf,onlineTime:2024-10-27T16:00:00.000+0000,startPage:37,endPage:bH,accessCount:2260,downloadPdfCount:194,isDeleted:b,createTime:2024-10-28T09:10:36.000+0000,updateTime:2025-08-01T19:17:36.000+0000,status:b,sorted:bf,cancelTime:a,pdfSize:21.78 MB,keywordRich:\u003Cp\u003ECysteine sulfinate; Decarboxylase; Type I endometrial carcinoma; Prognosis; Proliferation; Apoptosis\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EExpression and clinical significance of CSAD in type I endometrial carcinoma\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(24)01689-9,academicEditor:a},{id:1944987865074024448,number:EJGO2024122202,doi:10.22514\u002Fejgo.2025.094,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Clinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study,author:Akbar Ibrahimov,Gunel Ziyadova,Mehmet Coskun Salman,authorMark:{name: Akbar Ibrahimov,email:akbaribrahimov@amu.edu.az,org:1 * ,Corresponding:1},{name: Gunel Ziyadova,org:2},{name: Mehmet Coskun Salman,org:3},submitted:2024-12-21T16:00:00.000+0000,accepted:2025-02-17T16:00:00.000+0000,published:a,releaseTime:k,keyword:Ovarian metastasis of the primary origin; Prognosis; Survival,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2081\u002Fpdf\u002FEJGO2024122202.pdf,onlineTime:a,startPage:46,endPage:53,accessCount:584,downloadPdfCount:136,isDeleted:b,createTime:2025-07-15T05:10:17.000+0000,updateTime:2025-08-01T19:17:52.000+0000,status:b,sorted:aa,cancelTime:a,pdfSize:1.16 MB,keywordRich:\u003Cp\u003EOvarian metastasis of the primary origin; Prognosis; Survival\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EClinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01938-2,academicEditor:a},{id:1944990111857819648,number:EJGO2023113001,doi:10.22514\u002Fejgo.2025.095,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Identification of a novel targeting peptide for cervical clear cell adenocarcinoma by in vivo phage display screening combined with immunofluorescent analysis,author:Juanli Yang,Xiaomin Liu,Xiaojuan He,Zheng Tang,authorMark:{name: Juanli Yang,org:1},{name: Xiaomin Liu,org:2},{name: Xiaojuan He,org:2},{name: Zheng Tang,email:tangzheng@usc.edu.cn,org:3 * ,Corresponding:1},submitted:2023-11-29T16:00:00.000+0000,accepted:2023-12-28T16:00:00.000+0000,published:a,releaseTime:k,keyword:Phage display; Cervical clear cell adenocarcinoma; Tumor-targeting peptides; Tumor targeting,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2082\u002Fpdf\u002FEJGO2023113001.pdf,onlineTime:a,startPage:bE,endPage:61,accessCount:523,downloadPdfCount:110,isDeleted:b,createTime:2025-07-15T05:19:13.000+0000,updateTime:2025-08-01T19:17:56.000+0000,status:b,sorted:D,cancelTime:a,pdfSize:27.26 MB,keywordRich:\u003Cp\u003EPhage display; Cervical clear cell adenocarcinoma; Tumor-targeting peptides; Tumor targeting\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EIdentification of a novel targeting peptide for cervical clear cell adenocarcinoma by \u003Ci\u003Ein vivo\u003C\u002Fi\u003E phage display screening combined with immunofluorescent analysis\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01939-4,academicEditor:a},{id:1944991882416144384,number:EJGO2024123102,doi:10.22514\u002Fejgo.2025.096,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:The incidence and clinical outcomes following prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: a single-center retrospective study,author:Tuğçe Sırma,Konul Mehdiyeva,Lena Türeyici,Gürdeniz Serin,Göktuğ Aydoğan,Aslı Ece Solmaz,Haluk Akın,Ahmet Aydın Özsaran,Mustafa Coşan Terek,Levent Akman,Nuri Yıldırım,authorMark:{name: Tuğçe Sırma,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-0098-8915},{name: Konul Mehdiyeva,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0157-3604},{name: Lena Türeyici,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-1075-2292},{name: Gürdeniz Serin,org:2,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-4204-0601},{name: Göktuğ Aydoğan,org:2,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-1885-6355},{name: Aslı Ece Solmaz,org:3,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-2540-5293},{name: Haluk Akın,org:3,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-1733-5555},{name: Ahmet Aydın Özsaran,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-4330-0228},{name: Mustafa Coşan Terek,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-0294-2857},{name: Levent Akman,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-9399-8049},{name: Nuri Yıldırım,email:nuri.yildirim@ege.edu.tr,org:1 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-0605-4750,Corresponding:1},submitted:bm,accepted:2025-04-06T16:00:00.000+0000,published:a,releaseTime:k,keyword:BRCA; Risk-reducing salpingo-oophorectomy; Serous tubal intraepithelial carcinoma,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2083\u002Fpdf\u002FEJGO2024123102.pdf,onlineTime:a,startPage:62,endPage:69,accessCount:637,downloadPdfCount:180,isDeleted:b,createTime:2025-07-15T05:26:15.000+0000,updateTime:2025-08-01T19:17:58.000+0000,status:b,sorted:ae,cancelTime:a,pdfSize:329.48 kB,keywordRich:\u003Cp\u003E\u003Ci\u003EBRCA\u003C\u002Fi\u003E; Risk-reducing salpingo-oophorectomy; Serous tubal intraepithelial carcinoma\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EThe incidence and clinical outcomes following prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: a single-center retrospective study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01940-0,academicEditor:a},{id:1944994153979887616,number:EJGO2024122301,doi:10.22514\u002Fejgo.2025.097,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Establishment of a predictive survival prognosis model for epithelial ovarian cancer: a study based on the SEER database,author:Xiaoli Yu,Ying Fan,Ying Liu,authorMark:{name: Xiaoli Yu,email:belovedyxl@163.com,org:1 * ,Corresponding:1},{name: Ying Fan,email:fanying0502@163.com,org:1 * ,Corresponding:1},{name: Ying Liu,org:1},submitted:bT,accepted:2025-06-03T16:00:00.000+0000,published:a,releaseTime:k,keyword:Epithelial ovarian cancer; SEER database; Overall survival; Prognosis; Prognostic factors,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2084\u002Fpdf\u002FEJGO2024122301.pdf,onlineTime:a,startPage:70,endPage:79,accessCount:588,downloadPdfCount:150,isDeleted:b,createTime:2025-07-15T05:35:17.000+0000,updateTime:2025-08-01T19:18:00.000+0000,status:b,sorted:bD,cancelTime:a,pdfSize:2.31 MB,keywordRich:\u003Cp\u003EEpithelial ovarian cancer; SEER database; Overall survival; Prognosis; Prognostic factors\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEstablishment of a predictive survival prognosis model for epithelial ovarian cancer: a study based on the SEER database\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01941-2,academicEditor:a},{id:1944995045475008512,number:EJGO2024123001,doi:10.22514\u002Fejgo.2025.098,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Awareness, attitudes and vaccination intentions regarding cervical cancer and HPV among healthcare workers,author:Yıldız Büyükdereli Atadağ,Aslıhan Çelik Çoban,authorMark:{name: Yıldız Büyükdereli Atadağ,email:yildizatadag@gantep.edu.tr,org:1 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-8516-6477,Corresponding:1},{name: Aslıhan Çelik Çoban,org:1,orcid:https:\u002F\u002Forcid.org\u002F0009-0009-8808-5224},submitted:2024-12-29T16:00:00.000+0000,accepted:2025-02-12T16:00:00.000+0000,published:a,releaseTime:k,keyword:Cervical cancer; Human papillomavirus (HPV); Family vaccination; Healthcare workers,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250717-2093\u002Fpdf\u002FEJGO2024123001.pdf,onlineTime:a,startPage:80,endPage:87,accessCount:608,downloadPdfCount:151,isDeleted:b,createTime:2025-07-15T05:38:49.000+0000,updateTime:2025-08-01T19:18:10.000+0000,status:b,sorted:az,cancelTime:a,pdfSize:bz,keywordRich:\u003Cp\u003ECervical cancer; Human papillomavirus (HPV); Family vaccination; Healthcare workers\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EAwareness, attitudes and vaccination intentions regarding cervical cancer and HPV among healthcare workers\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01942-4,academicEditor:a},{id:1944995979261296640,number:EJGO2025052202,doi:10.22514\u002Fejgo.2025.099,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Knockdown of PIMREG modulates the Wnt\u002Fβ-catenin pathway to suppress proliferation and stemness in endometrial cancer,author:Zhiqing Hu,Qing Wang,Jinyong Wang,Ronghua Qiu,authorMark:{name: Zhiqing Hu,org:1},{name: Qing Wang,org:2},{name: Jinyong Wang,org:1},{name: Ronghua Qiu,email:rh21_q5@163.com,org:1 * ,Corresponding:1},submitted:2025-05-21T16:00:00.000+0000,accepted:2025-06-22T16:00:00.000+0000,published:a,releaseTime:k,keyword:PIMREG; Wnt\u002Fβ-catenin pathway; Endometrial cancer; Stemness,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2086\u002Fpdf\u002FEJGO2025052202.pdf,onlineTime:a,startPage:88,endPage:94,accessCount:525,downloadPdfCount:147,isDeleted:b,createTime:2025-07-15T05:42:32.000+0000,updateTime:2025-08-01T19:18:17.000+0000,status:b,sorted:ax,cancelTime:a,pdfSize:8.98 MB,keywordRich:\u003Cp\u003E\u003Ci\u003EPIMREG\u003C\u002Fi\u003E; Wnt\u002F\u003Ci\u003Eβ\u003C\u002Fi\u003E-catenin pathway; Endometrial cancer; Stemness\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EKnockdown of \u003Ci\u003EPIMREG \u003C\u002Fi\u003Emodulates the Wnt\u002F\u003Ci\u003Eβ\u003C\u002Fi\u003E-catenin pathway to suppress proliferation and stemness in endometrial cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01943-6,academicEditor:a},{id:1944996803479781376,number:EJGO2025060301,doi:10.22514\u002Fejgo.2025.100,volumeId:g,issueId:l,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis,author:Yuhong Yang,Ting Feng,Nayu Shi,Lin Ma,Honger Xu,Xiaojuan Ke,authorMark:{name: Yuhong Yang,org:1},{name: Ting Feng,email:ftft7890227@163.com,org:1 * ,Corresponding:1},{name: Nayu Shi,org:1},{name: Lin Ma,org:1},{name: Honger Xu,org:1},{name: Xiaojuan Ke,org:1},submitted:2025-03-03T16:00:00.000+0000,accepted:2025-06-18T16:00:00.000+0000,published:a,releaseTime:k,keyword:Cervical cancer (CC); Echinacoside (Ech); Angiogenesis; Invasion; Wnt\u002Fβ-catenin axis,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2087\u002Fpdf\u002FEJGO2025060301.pdf,onlineTime:a,startPage:95,endPage:bx,accessCount:552,downloadPdfCount:am,isDeleted:b,createTime:2025-07-15T05:45:48.000+0000,updateTime:2025-08-01T19:18:22.000+0000,status:b,sorted:V,cancelTime:a,pdfSize:3.47 MB,keywordRich:\u003Cp\u003ECervical cancer (CC); Echinacoside (Ech); Angiogenesis; Invasion; Wnt\u002F\u003Ci\u003Eβ\u003C\u002Fi\u003E-catenin axis\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEchinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01944-8,academicEditor:a},{id:1944998563367796736,number:EJGO2024101404,doi:10.22514\u002Fejgo.2025.101,volumeId:g,issueId:l,typeId:m,typeName:O,specialId:a,specialTitle:a,isPreprinted:b,title:Integrating chemoradiotherapy and nivolumab in advanced cervical cancer: two case reports,author:Garima Tripathi,Daniel W. Qiu,Karen C. Wang,Hsin-Lun Lee,Tungho Wu,Jiantai Timothy Qiu,authorMark:{name: Garima Tripathi,org:1 2 3},{name: Daniel W. Qiu,org:1},{name: Karen C. Wang,org:4},{name: Hsin-Lun Lee,org:5},{name: Tungho Wu,org:5},{name: Jiantai Timothy Qiu,email:191010@h.tmu.edu.tw,org:1 2 6 * ,Corresponding:1},submitted:2024-10-13T16:00:00.000+0000,accepted:2024-12-03T16:00:00.000+0000,published:a,releaseTime:k,keyword:Cervical cancer; Nivolumab; Immunotherapy; Recurrent disease; Concurrent chemoradiotherapy and immune checkpoint inhibitors,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2088\u002Fpdf\u002FEJGO2024101404.pdf,onlineTime:a,startPage:103,endPage:bl,accessCount:600,downloadPdfCount:bj,isDeleted:b,createTime:2025-07-15T05:52:48.000+0000,updateTime:2025-08-01T19:18:30.000+0000,status:b,sorted:an,cancelTime:a,pdfSize:7.36 MB,keywordRich:\u003Cp\u003ECervical cancer; Nivolumab; Immunotherapy; Recurrent disease; Concurrent chemoradiotherapy and immune checkpoint inhibitors\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EIntegrating chemoradiotherapy and nivolumab in advanced cervical cancer: two case reports\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01945-X,academicEditor:a},{id:1945000201109291008,number:EJGO2025020601,doi:10.22514\u002Fejgo.2025.102,volumeId:g,issueId:l,typeId:m,typeName:O,specialId:aS,specialTitle:aU,isPreprinted:b,title:A case series of four patients with recurrent ovarian granulosa cell tumors treated with CDK4\u002F6 inhibitors and estrogen blockade in a pilot study,author:Gabriella A. DiBernardo,Andrea I. Nañez,Erica Manrriquez,Lauryn Ruegg,Steven S. Raman,Gottfried E. Konecny,Olga Olevsky,Puja Venkat,Sanaz Memarzadeh,authorMark:{name: Gabriella A. DiBernardo,org:1 2 †,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-8022-7288},{name: Andrea I. Nañez,org:3 †,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0374-8113},{name: Erica Manrriquez,org:4,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-2544-4420},{name: Lauryn Ruegg,org:1 2,orcid:https:\u002F\u002Forcid.org\u002F0009-0000-6314-2370},{name: Steven S. Raman,org:5,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0499-1676},{name: Gottfried E. Konecny,org:6,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-6083-657X},{name: Olga Olevsky,org:6},{name: Puja Venkat,org:7,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-4659-3342},{name: Sanaz Memarzadeh,email:smemarzadeh@mednet.ucla.edu,org:1 2 8 9 10 11 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-1533-1905,Corresponding:1},submitted:2025-02-05T16:00:00.000+0000,accepted:2025-04-14T16:00:00.000+0000,published:a,releaseTime:k,keyword:Granulosa cell tumor; CDK4\u002F6 inhibitor; Hormone therapy; Ovarian cancer; Palbociclib,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2089\u002Fpdf\u002FEJGO2025020601.pdf,onlineTime:a,startPage:am,endPage:bi,accessCount:572,downloadPdfCount:132,isDeleted:b,createTime:2025-07-15T05:59:19.000+0000,updateTime:2025-08-01T19:18:32.000+0000,status:b,sorted:N,cancelTime:a,pdfSize:9.37 MB,keywordRich:\u003Cp\u003EGranulosa cell tumor; CDK4\u002F6 inhibitor; Hormone therapy; Ovarian cancer; Palbociclib\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EA case series of four patients with recurrent ovarian granulosa cell tumors treated with CDK4\u002F6 inhibitors and estrogen blockade in a pilot study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01946-1,academicEditor:a},{id:1945001151744098304,number:EJGO2024102001,doi:10.22514\u002Fejgo.2025.103,volumeId:g,issueId:l,typeId:m,typeName:O,specialId:a,specialTitle:a,isPreprinted:b,title:Rare presentation of cervical choriocarcinoma with metastasis: a case report,author:Javeria Haider,Humera Mahmood,Muhammad Faheem,Shaista Khurshid,Abdullah,authorMark:{name: Javeria Haider,email:snaeem1959@gmail.com,org:1 * ,Corresponding:1},{name: Humera Mahmood,org:1},{name: Muhammad Faheem,org:1},{name: Shaista Khurshid,org:1},{name: Abdullah,org:2},submitted:2024-10-19T16:00:00.000+0000,accepted:2024-12-05T16:00:00.000+0000,published:a,releaseTime:k,keyword:Choriocarcinoma; Systemic chemotherapy; Gestational trophoblastic disease,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250715-2092\u002Fpdf\u002FEJGO2024102001.pdf,onlineTime:a,startPage:124,endPage:127,accessCount:549,downloadPdfCount:120,isDeleted:b,createTime:2025-07-15T06:03:05.000+0000,updateTime:2025-08-01T19:18:34.000+0000,status:b,sorted:c,cancelTime:a,pdfSize:1.6 MB,keywordRich:\u003Cp\u003EChoriocarcinoma; Systemic chemotherapy; Gestational trophoblastic disease\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ERare presentation of cervical choriocarcinoma with metastasis: a case report\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01947-3,academicEditor:a},moreArticleList:{id:1625725620433371136,number:EJGO2022070502,doi:10.22514\u002Fejgo.2023.001,volumeId:u,issueId:Q,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:Effectiveness of manual lymphatic drainage for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses,author:Wenting Xing,Dan Duan,Caixia Ye,Cheng Chen,Yonggui Ge,Yuanyuan Li,Haijuan Lin,Jiqi Wu,Wanqiang Chen,authorMark:{name: Wenting Xing,org:1 †},{name: Dan Duan,org:2 †},{name: Caixia Ye,org:1},{name: Cheng Chen,org:3},{name: Yonggui Ge,org:1},{name: Yuanyuan Li,org:2},{name: Haijuan Lin,org:1},{name: Jiqi Wu,org:1},{name: Wanqiang Chen,email:duand20@163.com,org:1 * ,Corresponding:1},submitted:2022-07-04T16:00:00.000+0000,accepted:ba,published:a,releaseTime:L,keyword:Manual lymphatic drainage; Breast cancer-related lymphoedema; Effectiveness; Overview,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20230215-1412\u002Fpdf\u002FEJGO2022070502.pdf,onlineTime:a,startPage:c,endPage:16,accessCount:6705,downloadPdfCount:527,isDeleted:b,createTime:2023-02-15T05:16:07.000+0000,updateTime:2025-08-01T15:25:22.000+0000,status:b,sorted:M,cancelTime:a,pdfSize:bd,keywordRich:\u003Cp\u003EManual lymphatic drainage; Breast cancer-related lymphoedema; Effectiveness; Overview\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEffectiveness of manual lymphatic drainage for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)01355-4,academicEditor:a,volume:{id:u,year:aF,number:ad,isDeleted:b,createTime:J,updateTime:J,sorted:a},issue:{id:Q,volumeId:u,issueDate:bc,number:s,isDeleted:b,createTime:a$,updateTime:L,picture:a_,isReleased:c,releaseTime:L,sorted:a}},{id:1517411910196051968,number:EJGO22012702,doi:10.31083\u002Fj.ejgo4302041,volumeId:e,issueId:x,typeId:n,typeName:p,specialId:aX,specialTitle:aV,isPreprinted:b,title:Management of malignant dysgerminoma of the ovary,author:Tjadina Arndt,Eliane Tabea Taube,Hedwig E. Deubzer,Karin Rothe,Gabriele Calaminus,Jalid Sehouli,Klaus Pietzner,authorMark:{name: Tjadina Arndt,email:tjadina.arndt@charite.de,org:1 2 * ,Corresponding:1},{name: Eliane Tabea Taube,org:3},{name: Hedwig E. Deubzer,org:4 5 6},{name: Karin Rothe,org:7},{name: Gabriele Calaminus,org:8},{name: Jalid Sehouli,org:9},{name: Klaus Pietzner,org:9},submitted:2022-01-28T16:00:00.000+0000,accepted:2022-03-08T16:00:00.000+0000,published:a,releaseTime:2022-05-09T06:29:33.000+0000,keyword:non epithelial ovarian cancer; ovarian germ cell tumor; dysgerminoma; surgery; chemotherapy; targeted therapies.,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-65\u002Fpdf\u002FEJGO22012702.pdf,onlineTime:a,startPage:353,endPage:362,accessCount:5164,downloadPdfCount:548,isDeleted:b,createTime:2022-04-22T07:56:07.000+0000,updateTime:2025-08-01T19:09:50.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:10.63 MB,keywordRich:\u003Cp\u003Enon epithelial ovarian cancer; ovarian germ cell tumor; dysgerminoma; surgery; chemotherapy; targeted therapies.\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EManagement of malignant dysgerminoma of the ovary\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00063-6,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:x,volumeId:e,issueDate:W,number:m,isDeleted:b,createTime:P,updateTime:z,picture:Y,isReleased:c,releaseTime:z,sorted:a}},{id:1699702630444351488,number:EJGO2023042501,doi:10.22514\u002Fejgo.2023.070,volumeId:h,issueId:Z,typeId:m,typeName:O,specialId:a,specialTitle:a,isPreprinted:b,title:Vulvar cancer in young woman—case report,author:Miloš Pantelić,Branislava Baturan,Marko Stojić,Ljiljana Mladenović-Segedi,Milana Panjković,Anita Krsman,authorMark:{name: Miloš Pantelić,org:1 2 †},{name: Branislava Baturan,email:branislava.baturan@mf.uns.ac.rs,org:1 2 * † ,Corresponding:1},{name: Marko Stojić,org:1 2},{name: Ljiljana Mladenović-Segedi,org:1 2},{name: Milana Panjković,org:1 2},{name: Anita Krsman,org:1 2},submitted:2023-04-24T16:00:00.000+0000,accepted:2023-05-28T16:00:00.000+0000,published:a,releaseTime:G,keyword:Vulvar cancer; HPV infection; Young women; Lichen sclerosus,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20241015-1794\u002Fpdf\u002FEJGO2023042501.pdf,onlineTime:2023-09-06T16:00:00.000+0000,startPage:193,endPage:196,accessCount:5118,downloadPdfCount:386,isDeleted:b,createTime:2023-09-07T08:34:20.000+0000,updateTime:2025-08-01T14:43:19.000+0000,status:b,sorted:N,cancelTime:a,pdfSize:1.53 MB,keywordRich:\u003Cp\u003EVulvar cancer; HPV infection; Young women; Lichen sclerosus\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EVulvar cancer in young woman—case report\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00056-6,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:Z,volumeId:h,issueDate:aQ,number:w,isDeleted:b,createTime:aM,updateTime:G,picture:aK,isReleased:c,releaseTime:G,sorted:a}},{id:1518165678344814592,number:EJGO21060401,doi:10.31083\u002Fj.ejgo4206181,volumeId:o,issueId:aH,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States,author:Matthew J. Monberg,Jennifer P. Hall,Rebecca Moon,Keerun Khela,authorMark:{name: Matthew J. Monberg,email:matthew.monberg@merck.com,org:1 * ,Corresponding:1},{name: Jennifer P. Hall,org:2},{name: Rebecca Moon,org:2},{name: Keerun Khela,org:2},submitted:2021-06-03T16:00:00.000+0000,accepted:2021-07-20T16:00:00.000+0000,published:a,releaseTime:2022-04-24T09:51:32.000+0000,keyword:Bevacizumab; Chemotherapy; First-line; Maintenance; Ovarian cancer; Realworld,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220424-69\u002Fpdf\u002FEJGO21060401.pdf,onlineTime:a,startPage:1252,endPage:1261,accessCount:4498,downloadPdfCount:313,isDeleted:b,createTime:2022-04-24T09:51:18.000+0000,updateTime:2025-08-01T19:24:27.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:346.46 kB,keywordRich:\u003Cp\u003EBevacizumab; Chemotherapy; First-line; Maintenance; Ovarian cancer; Realworld\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EReal-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00067-5,academicEditor:a,volume:{id:o,year:ac,number:ab,isDeleted:b,createTime:t,updateTime:t,sorted:a},issue:{id:aH,volumeId:o,issueDate:2021-12-14T16:00:00.000+0000,number:d,isDeleted:b,createTime:2022-04-21T07:42:23.000+0000,updateTime:aJ,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F42\u002Fissue\u002FEJGO-2021-v42-i6.jpg,isReleased:c,releaseTime:aJ,sorted:a}},{id:1517427670884728832,number:EJGO5045,doi:10.31083\u002Fj.ejgo.2020.05.5045,volumeId:aD,issueId:aL,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer,author:Lingyun Zhai,Lixin Zeng,Hongru Jiang,Wei Li,authorMark:{name: Lingyun Zhai,org:1},{name: Lixin Zeng,org:2},{name: Hongru Jiang,org:3},{name: Wei Li,email:wei5901482@hotmail.com,org:2 * ,Corresponding:1},submitted:2018-10-12T16:00:00.000+0000,accepted:2019-05-01T16:00:00.000+0000,published:a,releaseTime:aB,keyword:Epithelial ovarian cancer; SC-560; Cisplatin; Taxol; Cyclin D1; Apoptosis; Vascular endothelial growth factor.,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-80\u002Fpdf\u002FEJGO5045.pdf,onlineTime:a,startPage:779,endPage:784,accessCount:4283,downloadPdfCount:bl,isDeleted:b,createTime:2022-04-22T08:58:44.000+0000,updateTime:2025-08-01T17:10:54.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:2.09 MB,keywordRich:\u003Cp\u003EEpithelial ovarian cancer; SC-560; Cisplatin; Taxol; Cyclin D1; Apoptosis; Vascular endothelial growth factor.\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEffects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00078-8,academicEditor:a,volume:{id:aD,year:2019-12-31T16:00:00.000+0000,number:41,isDeleted:b,createTime:aN,updateTime:aN,sorted:a},issue:{id:aL,volumeId:aD,issueDate:2020-10-14T16:00:00.000+0000,number:w,isDeleted:b,createTime:2022-04-22T07:19:51.000+0000,updateTime:aB,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F41\u002Fissue\u002FEJGO-2020-v41-i5.jpg,isReleased:c,releaseTime:aB,sorted:a}},{id:1580796576202145792,number:EJGO2022047,doi:10.22514\u002Fejgo.2022.042,volumeId:e,issueId:E,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Gym-based aerobic exercise with bicycle ergometer contributes to the regression of human papilloma virus infection: a single-center, single-blind and randomized controlled trial,author:Ai-Wei Xiong,Ting Miao,Kai-Hua Wu,Shu-Li Zhao,Min-Min Yu,authorMark:{name: Ai-Wei Xiong,org:1},{name: Ting Miao,org:2},{name: Kai-Hua Wu,org:1},{name: Shu-Li Zhao,org:3},{name: Min-Min Yu,email:yuminmin324@126.com,org:1 * ,Corresponding:1},submitted:2022-06-04T16:00:00.000+0000,accepted:2022-06-30T16:00:00.000+0000,published:a,releaseTime:C,keyword:Aerobic exercise; Human papilloma virus; Cervical cancer; Regression,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20221014-1325\u002Fpdf\u002FEJGO2022047.pdf,onlineTime:a,startPage:au,endPage:bE,accessCount:4173,downloadPdfCount:198,isDeleted:b,createTime:2022-10-14T05:44:08.000+0000,updateTime:2025-08-01T16:54:52.000+0000,status:b,sorted:D,cancelTime:a,pdfSize:596.43 kB,keywordRich:\u003Cp\u003EAerobic exercise; Human papilloma virus; Cervical cancer; Regression\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EGym-based aerobic exercise with bicycle ergometer contributes to the regression of human papilloma virus infection: a single-center, single-blind and randomized controlled trial\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)01279-7,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:E,volumeId:e,issueDate:aA,number:w,isDeleted:b,createTime:ay,updateTime:C,picture:as,isReleased:c,releaseTime:C,sorted:a}},{id:1745691943279443968,number:EJGO2023100201,doi:10.22514\u002Fejgo.2024.001,volumeId:h,issueId:aT,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia,author:Hayfa A. AlHefdhi,Asma Saad Habbash,Safar Abadi Al-Saleem,Fatima Riaz,Syed Esam Mahmood,Amal A. AlHefdhi,Saad Abdullah Al Hatim,Abdullah Ali Alqahtani,Naif Shalan Alalyani,Saeed Abdullah Alahmari,Fahad Juwayid Alqahtani,Rawan Hassan Alshehri,authorMark:{name: Hayfa A. AlHefdhi,org:1},{name: Asma Saad Habbash,org:1},{name: Safar Abadi Al-Saleem,org:1},{name: Fatima Riaz,org:1},{name: Syed Esam Mahmood,email:smahmood@kku.edu.sa,org:1 * ,Corresponding:1},{name: Amal A. AlHefdhi,org:2},{name: Saad Abdullah Al Hatim,org:3},{name: Abdullah Ali Alqahtani,org:3},{name: Naif Shalan Alalyani,org:3},{name: Saeed Abdullah Alahmari,org:3},{name: Fahad Juwayid Alqahtani,org:3},{name: Rawan Hassan Alshehri,org:3},submitted:2023-10-01T16:00:00.000+0000,accepted:2023-10-31T16:00:00.000+0000,published:a,releaseTime:ap,keyword:Breast cancer; Screening; Risk factors; Outcomes,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240614-1247\u002Fpdf\u002FEJGO2023100201.pdf,onlineTime:2024-01-11T16:00:00.000+0000,startPage:bx,endPage:113,accessCount:4084,downloadPdfCount:204,isDeleted:b,createTime:2024-01-12T06:19:27.000+0000,updateTime:2025-08-01T15:00:53.000+0000,status:b,sorted:D,cancelTime:a,pdfSize:2.63 MB,keywordRich:\u003Cp\u003EBreast cancer; Screening; Risk factors; Outcomes\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EBreast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(24)00099-8,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:aT,volumeId:h,issueDate:2024-06-14T16:00:00.000+0000,number:n,isDeleted:b,createTime:2024-06-14T05:07:22.000+0000,updateTime:ap,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F45\u002Fissue\u002FMRE-EJGO-2024v45i3.jpg,isReleased:c,releaseTime:ap,sorted:a}},{id:1683397797827493888,number:EJGO2023031205,doi:10.22514\u002Fejgo.2023.051,volumeId:g,issueId:I,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Prognostic value of Ki-67 in patients with ovarian cancer,author:Su Wan,Chang Su,Yong Wang,Jin Ding,Qingya Jiang,Huafeng Ding,Guantai Ni,authorMark:{name: Su Wan,org:1 2},{name: Chang Su,org:1},{name: Yong Wang,org:3},{name: Jin Ding,org:1},{name: Qingya Jiang,org:1},{name: Huafeng Ding,email:dinghuafeng@wnmc.edu.cn,org:1 * ,Corresponding:1},{name: Guantai Ni,email:niguantai@yjsyy.com,org:1 * ,Corresponding:1},submitted:2023-03-11T16:00:00.000+0000,accepted:2023-05-04T16:00:00.000+0000,published:a,releaseTime:v,keyword:Ki-67; Ovarian cancer; Survival; Prognosis,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250115-1964\u002Fpdf\u002FEJGO2023031205.pdf,onlineTime:2023-07-23T16:00:00.000+0000,startPage:76,endPage:81,accessCount:4041,downloadPdfCount:322,isDeleted:b,createTime:2023-07-24T08:44:45.000+0000,updateTime:2025-08-01T11:24:34.000+0000,status:b,sorted:D,cancelTime:a,pdfSize:1.68 MB,keywordRich:\u003Cp\u003EKi-67; Ovarian cancer; Survival; Prognosis\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EPrognostic value of Ki-67 in patients with ovarian cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00037-2,academicEditor:a,volume:{id:g,year:T,number:S,isDeleted:b,createTime:y,updateTime:y,sorted:a},issue:{id:I,volumeId:g,issueDate:ai,number:s,isDeleted:b,createTime:ah,updateTime:v,picture:ag,isReleased:c,releaseTime:v,sorted:a}},{id:1516965113724059648,number:EJGO21101901,doi:10.31083\u002Fj.ejgo4301003,volumeId:e,issueId:bb,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:Efficacy of sonohysterography and hysteroscopy for evaluation of endometrial lesions in tamoxifen treated patients: a systematic review,author:Federica Di Guardo,Giosuè Giordano Incognito,Chiara Lello,Gisella D’Urso,Fortunato Genovese,Marco Palumbo,authorMark:{name: Federica Di Guardo,email:fediguardo@gmail.com ,org:1 * ,Corresponding:1},{name: Giosuè Giordano Incognito,org:1},{name: Chiara Lello,org:2},{name: Gisella D’Urso,org:1},{name: Fortunato Genovese,org:1},{name: Marco Palumbo,org:1},submitted:2021-10-19T16:00:00.000+0000,accepted:2022-01-04T16:00:00.000+0000,published:a,releaseTime:af,keyword:Hysteroscopy; Hysterosonography; Sonohysterography; Tamoxifen; Breast cancer,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220421-14\u002Fpdf\u002FEJGO21101901.pdf,onlineTime:a,startPage:78,endPage:86,accessCount:3865,downloadPdfCount:246,isDeleted:b,createTime:2022-04-21T02:20:41.000+0000,updateTime:2025-07-31T10:03:17.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:774.5 kB,keywordRich:\u003Cp\u003EHysteroscopy; Hysterosonography; Sonohysterography; Tamoxifen; Breast cancer\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEfficacy of sonohysterography and hysteroscopy for evaluation of endometrial lesions in tamoxifen treated patients: a systematic review\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00012-0,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:bb,volumeId:e,issueDate:2022-02-14T16:00:00.000+0000,number:s,isDeleted:b,createTime:i,updateTime:af,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F43\u002Fissue\u002FEJGOv43i1-v1.png,isReleased:c,releaseTime:af,sorted:a}},{id:1529383600698343424,number:EJGO3714,doi:10.12892\u002Fejgo3714.2017,volumeId:K,issueId:be,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:Omentectomy in endometrial cancer: an evidence-based insight,author:M.R. Brincat,Y. Muscat Baron,E. Borg,authorMark:{name: M.R. Brincat,email:mark.a.brincat@gov.mt,org:1 * ,Corresponding:1},{name: Y. Muscat Baron,org:2},{name: E. Borg,org:3},submitted:a,accepted:a,published:a,releaseTime:aw,keyword:Ovarian carcinoma; Omentum; Endometrial cancer; Evidence-based study.,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220525-861\u002Fpdf\u002FEJGO3714.pdf,onlineTime:a,startPage:bI,endPage:515,accessCount:3783,downloadPdfCount:236,isDeleted:b,createTime:2022-05-25T08:47:19.000+0000,updateTime:2025-08-01T19:25:07.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:351.59 kB,keywordRich:\u003Cp\u003E\u003C\u002Fp\u003E\u003Cp\u003EOvarian carcinoma; Omentum; Endometrial cancer; Evidence-based study.\u003C\u002Fp\u003E,titleRich:\u003Cp\u003E\u003C\u002Fp\u003E\u003Cp\u003EOmentectomy in endometrial cancer: an evidence-based insight\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00838-5,academicEditor:a,volume:{id:K,year:bg,number:bh,isDeleted:b,createTime:X,updateTime:X,sorted:a},issue:{id:be,volumeId:K,issueDate:2017-08-09T16:00:00.000+0000,number:at,isDeleted:b,createTime:2022-05-23T08:45:27.000+0000,updateTime:aw,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F38\u002Fissue\u002FEJGO-2017-v38-i4.jpg,isReleased:c,releaseTime:aw,sorted:a}},{id:1823958191867609088,number:EJGO2023121201,doi:10.22514\u002Fejgo.2024.062,volumeId:h,issueId:bk,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:p16\u002FKi-67 dual staining as a predictive value for cervical cancer compared to other conventional triage tools: a descriptive literature review,author:Ana Acosta Bedon,Dayanara Delgado-López,Cristina Ochoa-Avilés,Roque Rivas-Párraga,Bernardo Vega Crespo,Veronique Verhoeven,Vivian Alejandra Neira,authorMark:{name: Ana Acosta Bedon,org:1 †},{name: Dayanara Delgado-López,org:1 †},{name: Cristina Ochoa-Avilés,org:2},{name: Roque Rivas-Párraga,org:3},{name: Bernardo Vega Crespo,org:1},{name: Veronique Verhoeven,org:4},{name: Vivian Alejandra Neira,email:vivian.neira@ucuenca.edu.ec,org:2 5 * ,Corresponding:1},submitted:2023-12-11T16:00:00.000+0000,accepted:2024-01-16T16:00:00.000+0000,published:a,releaseTime:ar,keyword:Dual staining; p16; Ki-67; Cytology; Cervical cancer,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240815-1613\u002Fpdf\u002FEJGO2023121201.pdf,onlineTime:a,startPage:c,endPage:M,accessCount:3748,downloadPdfCount:355,isDeleted:b,createTime:2024-08-15T05:41:35.000+0000,updateTime:2025-08-01T19:28:36.000+0000,status:b,sorted:ao,cancelTime:a,pdfSize:1.79 MB,keywordRich:\u003Cp\u003EDual staining; p16; Ki-67; Cytology; Cervical cancer\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003Ep16\u002FKi-67 dual staining as a predictive value for cervical cancer compared to other conventional triage tools: a descriptive literature review\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(24)01554-7,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:bk,volumeId:h,issueDate:2024-08-14T16:00:00.000+0000,number:at,isDeleted:b,createTime:2024-08-15T05:35:55.000+0000,updateTime:ar,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F45\u002Fissue\u002FMRE-EJGO-2024v45i4.jpg,isReleased:c,releaseTime:ar,sorted:a}},{id:1518158995585417216,number:EJGO21122801,doi:10.22514\u002Fejgo.2022.003,volumeId:e,issueId:bn,typeId:n,typeName:p,specialId:bo,specialTitle:bp,isPreprinted:b,title:Surgical management in the pelvis for patients with advanced ovarian cancer,author:Andrea Giannini,Kristina A. Butler,authorMark:{name: Andrea Giannini,email:Giannini.Andrea@mayo.edu,org:1 2 * ,Corresponding:1},{name: Kristina A. Butler,email:Butler.Kristina@mayo.edu,org:1 * ,Corresponding:1},submitted:2021-12-27T16:00:00.000+0000,accepted:2022-03-15T16:00:00.000+0000,published:a,releaseTime:2022-06-16T01:15:50.000+0000,keyword:Radical surgery; Epithelial ovarian cancer; Frozen pelvis; Radical oophorectomy,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220617-1125\u002Fpdf\u002FEJGO21122801.pdf,onlineTime:2022-04-23T16:00:00.000+0000,startPage:D,endPage:aZ,accessCount:3709,downloadPdfCount:309,isDeleted:b,createTime:2022-04-24T09:24:45.000+0000,updateTime:2025-08-01T18:46:03.000+0000,status:b,sorted:aC,cancelTime:a,pdfSize:994.59 kB,keywordRich:\u003Cp\u003ERadical surgery; Epithelial ovarian cancer; Frozen pelvis; Radical oophorectomy\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ESurgical management in the pelvis for patients with advanced ovarian cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00052-3,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:bn,volumeId:e,issueDate:2022-06-14T16:00:00.000+0000,number:n,isDeleted:b,createTime:2022-06-15T03:25:18.000+0000,updateTime:bq,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F43\u002Fissue\u002FEJGO-v43i3.png,isReleased:c,releaseTime:bq,sorted:a}},{id:1518162304161464320,number:EJGO2246,doi:10.31083\u002Fj.ejgo.2021.02.2246,volumeId:o,issueId:br,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:The effect of vitamin D on the regression of human papilloma virus infection and metabolic parameters: a retrospective study,author:Sumeyra Koc,Sefa Kurt,Orkun Ilgen,Hikmet Tunc Timur,Turhan Uslu,authorMark:{name: Sumeyra Koc,org:1},{name: Sefa Kurt,org:1},{name: Orkun Ilgen,email:mdorkunilgen@gmail.com,org:1 * ,Corresponding:1},{name: Hikmet Tunc Timur,org:1},{name: Turhan Uslu,org:1},submitted:2020-09-13T16:00:00.000+0000,accepted:2020-12-19T16:00:00.000+0000,published:a,releaseTime:2022-04-24T09:38:10.000+0000,keyword:Human papillomavirus; Pap smear; Vitamin D,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220424-61\u002Fpdf\u002FEJGO2246.pdf,onlineTime:a,startPage:bs,endPage:345,accessCount:3561,downloadPdfCount:199,isDeleted:b,createTime:2022-04-24T09:37:54.000+0000,updateTime:2025-08-01T19:35:40.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:181.45 kB,keywordRich:\u003Cp\u003EHuman papillomavirus; Pap smear; Vitamin D\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EThe effect of vitamin D on the regression of human papilloma virus infection and metabolic parameters: a retrospective study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00059-6,academicEditor:a,volume:{id:o,year:ac,number:ab,isDeleted:b,createTime:t,updateTime:t,sorted:a},issue:{id:br,volumeId:o,issueDate:2021-04-14T16:00:00.000+0000,number:m,isDeleted:b,createTime:2022-04-21T07:37:17.000+0000,updateTime:bt,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F42\u002Fissue\u002FEJGO-2021-v42-i2.jpg,isReleased:c,releaseTime:bt,sorted:a}},{id:1712395373532594176,number:EJGO2023032001,doi:10.22514\u002Fejgo.2023.073,volumeId:h,issueId:Z,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients,author:Tianyi Liu,Xinyu Wang,Manyu Li,Tianyu Zhu,Cheng Qiu,Chuhan He,Lanyu Li,Jinfeng Qu,authorMark:{name: Tianyi Liu,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-6308-8076},{name: Xinyu Wang,org:2},{name: Manyu Li,org:3},{name: Tianyu Zhu,org:4},{name: Cheng Qiu,org:5},{name: Chuhan He,org:6},{name: Lanyu Li,org:7},{name: Jinfeng Qu,email:qjf2810@zxyy.cn,org:7 * ,Corresponding:1},submitted:2023-03-19T16:00:00.000+0000,accepted:bu,published:a,releaseTime:G,keyword:Cuproptosis; LncRNA; Endometrial carcinoma; Prognosis; LINC01224,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20241015-1792\u002Fpdf\u002FEJGO2023032001.pdf,onlineTime:2023-10-11T16:00:00.000+0000,startPage:72,endPage:82,accessCount:3501,downloadPdfCount:224,isDeleted:b,createTime:2023-10-12T09:10:47.000+0000,updateTime:2025-08-01T16:34:25.000+0000,status:b,sorted:aq,cancelTime:a,pdfSize:25.23 MB,keywordRich:\u003Cp\u003ECuproptosis; LncRNA; Endometrial carcinoma; Prognosis; LINC01224\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EIdentification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00059-1,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:Z,volumeId:h,issueDate:aQ,number:w,isDeleted:b,createTime:aM,updateTime:G,picture:aK,isReleased:c,releaseTime:G,sorted:a}},{id:1603266856547696640,number:EJGO2022090,doi:10.22514\u002Fejgo.2022.053,volumeId:e,issueId:bv,typeId:w,typeName:bw,specialId:a,specialTitle:a,isPreprinted:b,title:Traditional Chinese medicine for bone metastasis of breast cancer: a systematic review and meta-analysis,author:Cheng Qian,Huwei Bian,Tao Jiang,authorMark:{name: Cheng Qian,org:1},{name: Huwei Bian,org:1},{name: Tao Jiang,email:doctorjt88@163.com,org:1 * ,Corresponding:1},submitted:2022-06-25T16:00:00.000+0000,accepted:2022-07-07T16:00:00.000+0000,published:a,releaseTime:al,keyword:Traditional Chinese medicine; Bone metastasis; Breast cancer; Meta-analysis; Systematic review,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20221215-1403\u002Fpdf\u002FEJGO2022090.pdf,onlineTime:a,startPage:av,endPage:20,accessCount:3487,downloadPdfCount:232,isDeleted:b,createTime:2022-12-15T05:53:00.000+0000,updateTime:2025-08-01T16:17:55.000+0000,status:b,sorted:av,cancelTime:a,pdfSize:4.32 MB,keywordRich:\u003Cp\u003ETraditional Chinese medicine; Bone metastasis; Breast cancer; Meta-analysis; Systematic review\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ETraditional Chinese medicine for bone metastasis of breast cancer: a systematic review and meta-analysis\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)01342-0,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:bv,volumeId:e,issueDate:2022-12-14T16:00:00.000+0000,number:d,isDeleted:b,createTime:2022-12-15T05:34:19.000+0000,updateTime:al,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F43\u002Fissue\u002FEJGO-v43i6.png,isReleased:c,releaseTime:al,sorted:a}},{id:1702582291495043072,number:EJGO2023062602,doi:10.22514\u002Fejgo.2023.072,volumeId:g,issueId:by,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature,author:Yuemei Cheng,Pingyuan Yu,Xiaolei Liang,Yongxiu Yang,authorMark:{name: Yuemei Cheng,org:1},{name: Pingyuan Yu,org:1},{name: Xiaolei Liang,org:2},{name: Yongxiu Yang,email:yangyx@lzu.edu.cn,org:2 * ,Corresponding:1},submitted:2023-06-25T16:00:00.000+0000,accepted:2023-08-22T16:00:00.000+0000,published:a,releaseTime:ak,keyword:Endometrial cancer; Immune; Metabolic; Immune infiltration; Immunotherapy; Prognostic signature,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250214-1993\u002Fpdf\u002FEJGO2023062602.pdf,onlineTime:bA,startPage:au,endPage:bB,accessCount:3411,downloadPdfCount:221,isDeleted:b,createTime:2023-09-15T07:17:05.000+0000,updateTime:2025-08-01T03:50:14.000+0000,status:b,sorted:aa,cancelTime:a,pdfSize:7.46 MB,keywordRich:\u003Cp\u003EEndometrial cancer; Immune; Metabolic; Immune infiltration; Immunotherapy; Prognostic signature\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EIdentification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00058-X,academicEditor:a,volume:{id:g,year:T,number:S,isDeleted:b,createTime:y,updateTime:y,sorted:a},issue:{id:by,volumeId:g,issueDate:2025-02-14T16:00:00.000+0000,number:m,isDeleted:b,createTime:2025-02-14T07:10:49.000+0000,updateTime:ak,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F46\u002Fissue\u002FMRE-EJGO-2025v46i2.jpg,isReleased:c,releaseTime:ak,sorted:a}},{id:1517381014369779712,number:EJGO21121003,doi:10.31083\u002Fj.ejgo4302036,volumeId:e,issueId:x,typeId:w,typeName:bw,specialId:aX,specialTitle:aV,isPreprinted:b,title:Educational programs for post-treatment breast cancer survivors: a systematic review,author:Katherine Jinghua Lin,Cecile A. Lengacher,Carmen S. Rodriguez,Laura A. Szalacha,Jennifer Wolgemuth,authorMark:{name: Katherine Jinghua Lin,email:jlin3@usf.edu ,org:1 * ,Corresponding:1},{name: Cecile A. Lengacher,org:1},{name: Carmen S. Rodriguez,org:1},{name: Laura A. Szalacha,org:1},{name: Jennifer Wolgemuth,org:1}\n,submitted:2021-12-09T16:00:00.000+0000,accepted:2022-01-24T16:00:00.000+0000,published:a,releaseTime:2022-05-09T06:29:44.000+0000,keyword:education; program; post-treatment; breast cancer,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-42\u002Fpdf\u002FEJGO21121003.pdf,onlineTime:a,startPage:285,endPage:bC,accessCount:3307,downloadPdfCount:318,isDeleted:b,createTime:2022-04-22T05:53:20.000+0000,updateTime:2025-08-01T12:28:40.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:2.19 MB,keywordRich:\u003Cp\u003Eeducation; program; post-treatment; breast cancer\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEducational programs for post-treatment breast cancer survivors: a systematic review\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00040-5,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:x,volumeId:e,issueDate:W,number:m,isDeleted:b,createTime:P,updateTime:z,picture:Y,isReleased:c,releaseTime:z,sorted:a}},{id:1702579918940848128,number:EJGO2023060101,doi:10.22514\u002Fejgo.2023.071,volumeId:h,issueId:U,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services,author:Fatih Şahin,Emine Aydın,Emine Ufuk Büyükkaya Öcal,Savaş Özdemir,Ali Murat Kasapoğlu,Özgür Akbayır,authorMark:{name: Fatih Şahin,email:fatih.sahin1@isu.edu.tr,org:1 * ,Corresponding:1},{name: Emine Aydın,org:1},{name: Emine Ufuk Büyükkaya Öcal,org:2},{name: Savaş Özdemir,org:1},{name: Ali Murat Kasapoğlu,org:2},{name: Özgür Akbayır,org:2},submitted:2023-05-31T16:00:00.000+0000,accepted:2023-07-12T16:00:00.000+0000,published:a,releaseTime:H,keyword:LEEP; Cervical dysplasia; Cervical intraepithelial neoplasia; Conization,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240227-472\u002Fpdf\u002FEJGO2023060101.pdf,onlineTime:bA,startPage:am,endPage:bi,accessCount:3193,downloadPdfCount:253,isDeleted:b,createTime:2023-09-15T07:07:40.000+0000,updateTime:2025-08-01T18:53:57.000+0000,status:b,sorted:ax,cancelTime:a,pdfSize:bd,keywordRich:\u003Cp\u003ELEEP; Cervical dysplasia; Cervical intraepithelial neoplasia; Conization\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEvaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00057-8,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:U,volumeId:h,issueDate:bF,number:s,isDeleted:b,createTime:j,updateTime:H,picture:bG,isReleased:c,releaseTime:H,sorted:a}},{id:1879425623704649728,number:EJGO2024070101,doi:10.22514\u002Fejgo.2025.007,volumeId:g,issueId:I,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Quality of life in patients with cervical cancer and endometrial cancer during adjuvant treatment—similarities and differences useful in personalized care,author:Joanna Trawińska,Joanna Ewa Skręt-Magierło,Edyta Czetyrbok,Joanna Bielatowicz,Alicja Szczepańska,Anna Rybicka,Sebastian Kowalski,Aleksander Myszka,Andrzej Skręt,Edyta Barnaś,Małgorzata Gawlik,Bogusław Gawlik,authorMark:{name: Joanna Trawińska,email:jtrawinska@ur.edu.pl,org:1 * † ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-4308-1547,Corresponding:1},{name: Joanna Ewa Skręt-Magierło,org:2 †,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-1679-264X},{name: Edyta Czetyrbok,org:1},{name: Joanna Bielatowicz,org:3,orcid:https:\u002F\u002Forcid.org\u002F0009-0008-8614-9442},{name: Alicja Szczepańska,org:4},{name: Anna Rybicka,org:5},{name: Sebastian Kowalski,org:6,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0826-6025},{name: Aleksander Myszka,org:2 7,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-2931-7920},{name: Andrzej Skręt,org:3,orcid:https:\u002F\u002Forcid.org\u002F0009-0003-4920-2818},{name: Edyta Barnaś,org:2,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-7567-3782},{name: Małgorzata Gawlik,org:8,orcid:https:\u002F\u002Forcid.org\u002F0009-0001-6916-3129},{name: Bogusław Gawlik,org:3,orcid:https:\u002F\u002Forcid.org\u002F0009-0000-2043-5341},submitted:2024-06-30T16:00:00.000+0000,accepted:2024-08-01T16:00:00.000+0000,published:a,releaseTime:v,keyword:Quality of life; Cervical cancer; Endometrial cancer; Adjuvant therapy,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250115-1978\u002Fpdf\u002FEJGO2024070101.pdf,onlineTime:a,startPage:bB,endPage:75,accessCount:3181,downloadPdfCount:235,isDeleted:b,createTime:2025-01-15T07:09:21.000+0000,updateTime:2025-08-01T18:58:29.000+0000,status:b,sorted:aa,cancelTime:a,pdfSize:356.24 kB,keywordRich:\u003Cp\u003EQuality of life; Cervical cancer; Endometrial cancer; Adjuvant therapy\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EQuality of life in patients with cervical cancer and endometrial cancer during adjuvant treatment—similarities and differences useful in personalized care\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01846-7,academicEditor:a,volume:{id:g,year:T,number:S,isDeleted:b,createTime:y,updateTime:y,sorted:a},issue:{id:I,volumeId:g,issueDate:ai,number:s,isDeleted:b,createTime:ah,updateTime:v,picture:ag,isReleased:c,releaseTime:v,sorted:a}},{id:1739559630321664000,number:EJGO2023080301,doi:10.22514\u002Fejgo.2023.112,volumeId:h,issueId:_,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Does coexistence of endometrial cancer and adenomyosis affect survival outcomes? A retrospective cohort study,author:Latife Gözde Buyuksahin,Mujde Can Ibanoglu,Azize Cemre Ozturk,Vakkas Korkmaz,Sadiman Kiykac Altinbas,Yaprak Engin-Ustun,authorMark:{name: Latife Gözde Buyuksahin,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-5623-8438},{name: Mujde Can Ibanoglu,email:mujdecan.ibanoglu@saglik.gov.tr,org:1 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-8413-2064,Corresponding:1},{name: Azize Cemre Ozturk,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-3428-8976},{name: Vakkas Korkmaz,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-8895-6864},{name: Sadiman Kiykac Altinbas,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-2773-9641},{name: Yaprak Engin-Ustun,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-1011-3848},submitted:2023-08-02T16:00:00.000+0000,accepted:2023-10-07T16:00:00.000+0000,published:a,releaseTime:F,keyword:Adenomyosis; Endometrial carcinoma; Prognostic factor; Survive,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240415-821\u002Fpdf\u002FEJGO2023080301.pdf,onlineTime:2023-12-25T16:00:00.000+0000,startPage:118,endPage:126,accessCount:3110,downloadPdfCount:174,isDeleted:b,createTime:2023-12-26T08:11:50.000+0000,updateTime:2025-08-01T19:38:47.000+0000,status:b,sorted:bD,cancelTime:a,pdfSize:321.03 kB,keywordRich:\u003Cp\u003EAdenomyosis; Endometrial carcinoma; Prognostic factor; Survive\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EDoes coexistence of endometrial cancer and adenomyosis affect survival outcomes? A retrospective cohort study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00098-0,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:_,volumeId:h,issueDate:bJ,number:m,isDeleted:b,createTime:bK,updateTime:F,picture:bL,isReleased:c,releaseTime:F,sorted:a}},{id:1529650186759880704,number:EJGO3688,doi:10.12892\u002Fejgo3688.2017,volumeId:K,issueId:bM,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:CDX2 expression in endometrial endometrioid adenocarcinoma,author:D. Arık,S. Kabukçuoğlu,authorMark:{name:D. Arık,email:denarik@hotmail.com,org:1 * ,Corresponding:1},{name: S. Kabukçuoğlu,org:1},submitted:a,accepted:a,published:a,releaseTime:aj,keyword:CDX2; Endometrium; Endometrioid adenocarcinoma.,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220526-884\u002Fpdf\u002FEJGO3688.pdf,onlineTime:a,startPage:704,endPage:707,accessCount:3027,downloadPdfCount:212,isDeleted:b,createTime:2022-05-26T02:26:38.000+0000,updateTime:2025-08-01T18:47:29.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:522.16 kB,keywordRich:\u003Cp\u003ECDX2; Endometrium; Endometrioid adenocarcinoma.\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ECDX2 expression in endometrial endometrioid adenocarcinoma\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00863-4,academicEditor:a,volume:{id:K,year:bg,number:bh,isDeleted:b,createTime:X,updateTime:X,sorted:a},issue:{id:bM,volumeId:K,issueDate:2017-10-09T16:00:00.000+0000,number:w,isDeleted:b,createTime:2022-05-23T08:46:22.000+0000,updateTime:aj,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F38\u002Fissue\u002FEJGO-2017-v38-i5.jpg,isReleased:c,releaseTime:aj,sorted:a}},{id:1580804915401244672,number:EJGO2022040,doi:10.22514\u002Fejgo.2022.049,volumeId:e,issueId:E,typeId:m,typeName:O,specialId:1518503094414917632,specialTitle:Gynecological Oncology Treatment: Recent Progress in Clinical Modalities,isPreprinted:b,title:Recurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review,author:Hanako Sato,Yasushi Kotani,Chiho Miyagawa,Tamaki Yahata,Kosuke Murakami,Hidekatsu Nakai,Tomoyuki Otani,Noriomi Matsumura,authorMark:{name: Hanako Sato,org:1},{name: Yasushi Kotani,email:y-kotani@med.kindai.ac.jp,org:1 * ,Corresponding:1},{name: Chiho Miyagawa,org:1},{name: Tamaki Yahata,org:1},{name: Kosuke Murakami,org:1},{name: Hidekatsu Nakai,org:1},{name: Tomoyuki Otani,org:1},{name: Noriomi Matsumura,org:1},submitted:2022-05-30T16:00:00.000+0000,accepted:2022-09-13T16:00:00.000+0000,published:a,releaseTime:2022-10-14T07:40:35.000+0000,keyword:Ovarian cancer; Low-grade serous carcinoma; Gemcitabine; Bevacizumab; Genetic mutation,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20221014-1332\u002Fpdf\u002FEJGO2022040.pdf,onlineTime:a,startPage:107,endPage:111,accessCount:2976,downloadPdfCount:242,isDeleted:b,createTime:2022-10-14T06:17:16.000+0000,updateTime:2025-08-01T17:54:12.000+0000,status:b,sorted:N,cancelTime:a,pdfSize:1.44 MB,keywordRich:\u003Cp\u003EOvarian cancer; Low-grade serous carcinoma; Gemcitabine; Bevacizumab; Genetic mutation\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ERecurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)01286-4,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:E,volumeId:e,issueDate:aA,number:w,isDeleted:b,createTime:ay,updateTime:C,picture:as,isReleased:c,releaseTime:C,sorted:a}},{id:1754760783774793728,number:EJGO2023060401,doi:10.22514\u002Fejgo.2024.020,volumeId:h,issueId:U,typeId:7,typeName:Short Communications,specialId:a,specialTitle:a,isPreprinted:b,title:Evaluation of AI-assisted colposcopy for detecting high-risk subtypes of human papillomavirus in CIN2,author:Takayuki Takahashi,Hikaru Matsuoka,Yusuke Kobayashi,Takashi Iwata,Kouji Banno,Wataru Yamagami,Gen Tamiya,authorMark:{name: Takayuki Takahashi,org:1 2},{name: Hikaru Matsuoka,org:1},{name: Yusuke Kobayashi,org:2},{name: Takashi Iwata,org:2},{name: Kouji Banno,org:2},{name: Wataru Yamagami,org:2},{name: Gen Tamiya,email:gen.tamiya@riken.jp,org:2 3 * ,Corresponding:1},submitted:2023-06-03T16:00:00.000+0000,accepted:2023-07-19T16:00:00.000+0000,published:a,releaseTime:H,keyword:Colposcopy; Artificial intelligence; Cervical intraepithelial neoplasia; Deep learning; Human papillomavirus,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240206-289\u002Fpdf\u002FEJGO2023060401.pdf,onlineTime:a,startPage:bj,endPage:146,accessCount:2965,downloadPdfCount:258,isDeleted:b,createTime:2024-02-06T06:55:47.000+0000,updateTime:2025-08-01T19:20:27.000+0000,status:b,sorted:c,cancelTime:a,pdfSize:936.98 kB,keywordRich:\u003Cp\u003EColposcopy; Artificial intelligence; Cervical intraepithelial neoplasia; Deep learning; Human papillomavirus\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EEvaluation of AI-assisted colposcopy for detecting high-risk subtypes of human papillomavirus in CIN2\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(24)00251-1,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:U,volumeId:h,issueDate:bF,number:s,isDeleted:b,createTime:j,updateTime:H,picture:bG,isReleased:c,releaseTime:H,sorted:a}},{id:1625729334632169472,number:EJGO2022072701,doi:10.22514\u002Fejgo.2023.002,volumeId:u,issueId:Q,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study,author:Talayeh S. Ghezelayagh,Emily S. Wu,Emma L. Barber,Minh D. Dao,Emese Zsiros,Renata R. Urban,Heidi J. Gray,Barbara A. Goff,Chirag A. Shah,Nikki L. Neubauer,James Y. Dai,Janos L. Tanyi,John B. Liao,authorMark:{name: Talayeh S. Ghezelayagh,email:tghezel@uw.edu,org:1 * † ,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-6216-8501,Corresponding:1},{name: Emily S. Wu,org:1 2 †,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0057-1199},{name: Emma L. Barber,org:3,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-4960-5433},{name: Minh D. Dao,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-5886-4122},{name: Emese Zsiros,org:4 5,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0142-7375},{name: Renata R. Urban,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-8967-3794},{name: Heidi J. Gray,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-3927-6739},{name: Barbara A. Goff,org:1,orcid:https:\u002F\u002Forcid.org\u002F0000-0003-0598-2843},{name: Chirag A. Shah,org:6,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-7275-4475},{name: Nikki L. Neubauer,org:3 7,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-9121-9494},{name: James Y. Dai,org:8,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-6479-9286},{name: Janos L. Tanyi,org:4,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-5657-3698},{name: John B. Liao,email:johnliao@uw.edu,org:1 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-3018-7879,Corresponding:1},submitted:2022-07-26T16:00:00.000+0000,accepted:2022-10-30T16:00:00.000+0000,published:a,releaseTime:L,keyword:Ovarian cancer; Bevacizumab; Overall survival; Platinum sensitivity; Fallopian tube cancer,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20230215-1413\u002Fpdf\u002FEJGO2022072701.pdf,onlineTime:a,startPage:bR,endPage:ao,accessCount:2934,downloadPdfCount:271,isDeleted:b,createTime:2023-02-15T05:30:52.000+0000,updateTime:2025-08-01T15:05:04.000+0000,status:b,sorted:bN,cancelTime:a,pdfSize:1.78 MB,keywordRich:\u003Cp\u003EOvarian cancer; Bevacizumab; Overall survival; Platinum sensitivity; Fallopian tube cancer\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ETiming and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)01356-6,academicEditor:a,volume:{id:u,year:aF,number:ad,isDeleted:b,createTime:J,updateTime:J,sorted:a},issue:{id:Q,volumeId:u,issueDate:bc,number:s,isDeleted:b,createTime:a$,updateTime:L,picture:a_,isReleased:c,releaseTime:L,sorted:a}},{id:1674620852654489600,number:EJGO2023040802,doi:10.22514\u002Fejgo.2023.048,volumeId:u,issueId:bO,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Association of HPV and sexually transmitted infections among patients with genital warts and asymptomatic individuals: a cross-sectional study,author:Eser Ağar,Seda Şahin Aker,authorMark:{name: Eser Ağar,email:eagar@gelisim.edu.tr,org:1 * ,orcid:https:\u002F\u002Forcid.org\u002F0000-0002-3364-799X,Corresponding:1},{name: Seda Şahin Aker,org:2,orcid:https:\u002F\u002Forcid.org\u002F0000-0001-6192-5726},submitted:2023-04-07T16:00:00.000+0000,accepted:bu,published:a,releaseTime:aE,keyword:HPV genotypes; STI co-infections; Ureaplasma parvum; Cervical infections; Cervical cancer risk,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20230815-70\u002Fpdf\u002FEJGO2023040802.pdf,onlineTime:2023-06-29T16:00:00.000+0000,startPage:145,endPage:155,accessCount:2920,downloadPdfCount:bQ,isDeleted:b,createTime:2023-06-30T03:28:18.000+0000,updateTime:2025-08-01T18:56:11.000+0000,status:b,sorted:an,cancelTime:a,pdfSize:2.01 MB,keywordRich:\u003Cp\u003EHPV genotypes; STI co-infections; Ureaplasma parvum; Cervical infections; Cervical cancer risk\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EAssociation of HPV and sexually transmitted infections among patients with genital warts and asymptomatic individuals: a cross-sectional study\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(23)00034-7,academicEditor:a,volume:{id:u,year:aF,number:ad,isDeleted:b,createTime:J,updateTime:J,sorted:a},issue:{id:bO,volumeId:u,issueDate:2023-08-14T16:00:00.000+0000,number:at,isDeleted:b,createTime:2023-08-15T08:27:50.000+0000,updateTime:aE,picture:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F44\u002Fissue\u002FMRE-EJGO-2023v44i4.jpg,isReleased:c,releaseTime:aE,sorted:a}},{id:1879436116028735488,number:EJGO2024071201,doi:10.22514\u002Fejgo.2025.012,volumeId:g,issueId:I,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Investigating deep learning approaches for cervical cancer diagnosis: a focus on modern image-based models,author:Ishak Pacal,authorMark:{name: Ishak Pacal,email:ishak.pacal@gdir.edu.tr,org:1 * ,Corresponding:1},submitted:2024-07-11T16:00:00.000+0000,accepted:2024-08-12T16:00:00.000+0000,published:a,releaseTime:v,keyword:Deep learning; CNNs and ViTs; Cervical cancer detection; Artificial intelligence in medicine,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20250115-1970\u002Fpdf\u002FEJGO2024071201.pdf,onlineTime:a,startPage:125,endPage:bP,accessCount:2893,downloadPdfCount:233,isDeleted:b,createTime:2025-01-15T07:51:03.000+0000,updateTime:2025-08-01T17:38:37.000+0000,status:b,sorted:V,cancelTime:a,pdfSize:7.67 MB,keywordRich:\u003Cp\u003EDeep learning; CNNs and ViTs; Cervical cancer detection; Artificial intelligence in medicine\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EInvestigating deep learning approaches for cervical cancer diagnosis: a focus on modern image-based models\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(25)01853-4,academicEditor:a,volume:{id:g,year:T,number:S,isDeleted:b,createTime:y,updateTime:y,sorted:a},issue:{id:I,volumeId:g,issueDate:ai,number:s,isDeleted:b,createTime:ah,updateTime:v,picture:ag,isReleased:c,releaseTime:v,sorted:a}},{id:1518426130589073408,number:EJGO2297,doi:10.31083\u002Fj.ejgo.2021.01.2297,volumeId:o,issueId:$,typeId:n,typeName:p,specialId:1516679821339312128,specialTitle:Minimally Invasive Surgery in Gynecologic Oncology,isPreprinted:b,title:The current evidence for the use of minimally-invasive surgery in endometrial cancer,author:Joseph J. Noh,Tae-Joong Kim,authorMark:{name: Joseph J. Noh,org:1},{name: Tae-Joong Kim,email:tj28.kim@gmail.com,org:1 * ,Corresponding:1},submitted:2020-10-01T16:00:00.000+0000,accepted:2020-12-20T16:00:00.000+0000,published:a,releaseTime:2022-05-09T06:34:55.000+0000,keyword:Endometrial cancer; Minimally-invasive surgery; Laparoscopy; Laparotomy; Gynecology,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220425-171\u002Fpdf\u002FEJGO2297.pdf,onlineTime:a,startPage:aq,endPage:ao,accessCount:2888,downloadPdfCount:281,isDeleted:b,createTime:2022-04-25T03:06:15.000+0000,updateTime:2025-08-01T19:41:38.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:193.72 kB,keywordRich:\u003Cp\u003EEndometrial cancer; Minimally-invasive surgery; Laparoscopy; Laparotomy; Gynecology\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EThe current evidence for the use of minimally-invasive surgery in endometrial cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)00168-1,academicEditor:a,volume:{id:o,year:ac,number:ab,isDeleted:b,createTime:t,updateTime:t,sorted:a},issue:{id:$,volumeId:o,issueDate:bS,number:s,isDeleted:b,createTime:t,updateTime:R,picture:bU,isReleased:c,releaseTime:R,sorted:a}},{id:1779744755466289152,number:EJGO2023061101,doi:10.22514\u002Fejgo.2024.022,volumeId:h,issueId:_,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:aW,author:Giancarlo Garuti,Paola Francesca Sagrada,Maurizio Mirra,Ottavia Fornaciari,Giovanna Centinaio,Andrea Finco,Marco Soligo,authorMark:{name: Giancarlo Garuti,email:giancarlo.garuti@asst-lodi.it,org:1 * ,Corresponding:1},{name: Paola Francesca Sagrada,org:2},{name: Maurizio Mirra,org:3},{name: Ottavia Fornaciari,org:1},{name: Giovanna Centinaio,org:1},{name: Andrea Finco,org:1},{name: Marco Soligo,org:1},submitted:2023-06-10T16:00:00.000+0000,accepted:2023-07-11T16:00:00.000+0000,published:a,releaseTime:F,keyword:Atypical endometrial hyperplasia; Endometrial cancer; Endometrial biopsy; Hysteroscopy,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20240415-805\u002Fpdf\u002FEJGO2023061101.pdf,onlineTime:a,startPage:ae,endPage:M,accessCount:2771,downloadPdfCount:247,isDeleted:b,createTime:2024-04-15T05:33:10.000+0000,updateTime:2025-08-01T19:17:33.000+0000,status:b,sorted:aC,cancelTime:a,pdfSize:5.44 MB,keywordRich:\u003Cp\u003EAtypical endometrial hyperplasia; Endometrial cancer; Endometrial biopsy; Hysteroscopy\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EHysteroscopic-view of endometrial atypical hyperplasia. A helpful diagnostic tool in the care and treatment process?\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(24)00763-0,academicEditor:a,volume:{id:h,year:A,number:B,isDeleted:b,createTime:j,updateTime:j,sorted:a},issue:{id:_,volumeId:h,issueDate:bJ,number:m,isDeleted:b,createTime:bK,updateTime:F,picture:bL,isReleased:c,releaseTime:F,sorted:a}},{id:1517373649297784832,number:EJGO2130,doi:10.31083\u002Fj.ejgo.2021.01.2130,volumeId:o,issueId:$,typeId:d,typeName:f,specialId:a,specialTitle:a,isPreprinted:b,title:Cytoplasmic pollen extract for treatment of menopausal symptoms in breast cancer patients: a case series report,author:Aldo Iop,Pamela Driol,Alessandra Zacchia,Manuela Miscoria,authorMark:{name: Aldo Iop,email:aldo.iop@aas2.sanita.fvg.it ,org:1 * ,Corresponding:1},{name: Pamela Driol,org:1},{name: Alessandra Zacchia,org:1},{name: Manuela Miscoria,org:1},submitted:2020-05-11T16:00:00.000+0000,accepted:2020-10-25T16:00:00.000+0000,published:a,releaseTime:2022-04-22T13:04:34.000+0000,keyword:Cytoplasmic pollen extract; Menopausal symptoms; Breast cancer patients; Quality of life; Non-hormonal therapy,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-40\u002Fpdf\u002FEJGO2130.pdf,onlineTime:a,startPage:bH,endPage:49,accessCount:2728,downloadPdfCount:216,isDeleted:b,createTime:2022-04-22T05:24:04.000+0000,updateTime:2025-08-01T19:35:03.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:669.09 kB,keywordRich:\u003Cp\u003ECytoplasmic pollen extract; Menopausal symptoms; Breast cancer patients; Quality of life; Non-hormonal therapy\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ECytoplasmic pollen extract for treatment of menopausal symptoms in breast cancer patients: a case series report\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00038-7,academicEditor:a,volume:{id:o,year:ac,number:ab,isDeleted:b,createTime:t,updateTime:t,sorted:a},issue:{id:$,volumeId:o,issueDate:bS,number:s,isDeleted:b,createTime:t,updateTime:R,picture:bU,isReleased:c,releaseTime:R,sorted:a}},{id:1580789726622695424,number:EJGO2022081,doi:10.22514\u002Fejgo.2022.038,volumeId:e,issueId:E,typeId:n,typeName:p,specialId:a,specialTitle:a,isPreprinted:b,title:Progress in therapeutic HPV vaccines: observations from clinical trials,author:Tao Zhou,Ran Liu,Jian-hua Wu,authorMark:{name: Tao Zhou,org:1 †},{name: Ran Liu,org:1 †},{name: Jian-hua Wu,email:wujh_chyy@163.com,org:1 * ,Corresponding:1},submitted:2022-06-21T16:00:00.000+0000,accepted:2022-07-18T16:00:00.000+0000,published:a,releaseTime:C,keyword:HPV; Peptide-based vaccine; Vector vaccine; DNA vaccine,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20221014-1319\u002Fpdf\u002FEJGO2022081.pdf,onlineTime:a,startPage:c,endPage:ae,accessCount:2725,downloadPdfCount:288,isDeleted:b,createTime:2022-10-14T05:16:55.000+0000,updateTime:2025-08-01T17:51:31.000+0000,status:b,sorted:M,cancelTime:a,pdfSize:bz,keywordRich:\u003Cp\u003EHPV; Peptide-based vaccine; Vector vaccine; DNA vaccine\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EProgress in therapeutic HPV vaccines: observations from clinical trials\u003C\u002Fp\u003E,fullTextId:a,pii:S0392-2936(22)01275-X,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:E,volumeId:e,issueDate:aA,number:w,isDeleted:b,createTime:ay,updateTime:C,picture:as,isReleased:c,releaseTime:C,sorted:a}},{id:1517392282078068736,number:EJGO21122304,doi:10.31083\u002Fj.ejgo4302039,volumeId:e,issueId:x,typeId:n,typeName:p,specialId:bo,specialTitle:bp,isPreprinted:b,title:Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review,author:Valentina Ghirardi,Rita Trozzi,Elena Giudice,Giovanni Scambia,Anna Fagotti,authorMark:{name: Valentina Ghirardi,org:1},{name: Rita Trozzi,org:1 2},{name: Elena Giudice,org:1 2},{name: Giovanni Scambia,org:1 2},\n{name: Anna Fagotti,email:anna.fagotti@unicatt.it ,org:1 2 * ,Corresponding:1},submitted:2021-12-26T16:00:00.000+0000,accepted:2022-01-18T16:00:00.000+0000,published:a,releaseTime:2022-05-09T06:31:29.000+0000,keyword:ovarian cancer; HIPEC; primary debulking surgery; interval debulking surgery; recurrent disease,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-44\u002Fpdf\u002FEJGO21122304.pdf,onlineTime:a,startPage:335,endPage:bs,accessCount:2707,downloadPdfCount:bQ,isDeleted:b,createTime:2022-04-22T06:38:06.000+0000,updateTime:2025-08-01T07:58:47.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:233.84 kB,keywordRich:\u003Cp\u003Eovarian cancer; HIPEC; primary debulking surgery; interval debulking surgery; recurrent disease\u003C\u002Fp\u003E,titleRich:\u003Cp\u003EHyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00042-9,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:x,volumeId:e,issueDate:W,number:m,isDeleted:b,createTime:P,updateTime:z,picture:Y,isReleased:c,releaseTime:z,sorted:a}},{id:1517324285569318912,number:EJGO21112202,doi:10.31083\u002Fj.ejgo4302040,volumeId:e,issueId:x,typeId:n,typeName:p,specialId:1516659214195277824,specialTitle:Breast Cancer,isPreprinted:b,title:Treatment Progress in Triple Negative Breast Cancer,author:Stefan Krämer,Christoph Rogmans,Dilek Saylan,Dominique Friedrich,Clayton Kraft,Gunther Rogmans,Marina Wirtz,Michael Friedrich,authorMark:{name: Stefan Krämer,org:1},{name: Christoph Rogmans,org:2},{name: Dilek Saylan,org:1},{name: Dominique Friedrich,org:1},{name: Clayton Kraft,org:1},{name: Gunther Rogmans,org:1},{name: Marina Wirtz,org:1},{name: Michael Friedrich,email:michael.friedrich@helios-gesundheit.de,org:1 * ,Corresponding:1},submitted:2021-11-21T16:00:00.000+0000,accepted:2022-02-17T16:00:00.000+0000,published:a,releaseTime:2022-05-09T06:30:13.000+0000,keyword:breast cancer; triple negative; chemotherapy; immunoncology; PD -L1; Parp; pembrolizumab; atezolizumab; olaparib; talozoparib; sacituzumab-govitecan,pdf:https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Farticle\u002F20220422-34\u002Fpdf\u002FEJGO21112202.pdf,onlineTime:a,startPage:bC,endPage:352,accessCount:2693,downloadPdfCount:241,isDeleted:b,createTime:2022-04-22T02:07:55.000+0000,updateTime:2025-08-01T03:12:14.000+0000,status:b,sorted:a,cancelTime:a,pdfSize:278.62 kB,keywordRich:\u003Cp\u003Ebreast cancer; triple negative; chemotherapy; immunoncology; PD -L1; Parp; pembrolizumab; atezolizumab; olaparib; talozoparib; sacituzumab-govitecan\u003C\u002Fp\u003E,titleRich:\u003Cp\u003ETreatment Progress in Triple Negative Breast Cancer\u003C\u002Fp\u003E,fullTextId:a,pii:S2768-6701(22)00032-6,academicEditor:a,volume:{id:e,year:q,number:r,isDeleted:b,createTime:i,updateTime:i,sorted:a},issue:{id:x,volumeId:e,issueDate:W,number:m,isDeleted:b,createTime:P,updateTime:z,picture:Y,isReleased:c,releaseTime:z,sorted:a}},pageContent:{HeaderAbout:\u003Ch2\u003E\u003Cfont face\Georgia\ size\5\\u003EEuropean Journal of Gynaecological Oncology\u003C\u002Ffont\u003E\u003C\u002Fh2\u003E\u003Cp\u003E\u003Cb style\\\u003E\u003Cfont size\1\\u003EPrint ISSN: 0392-2936 | Online ISSN: 2709-0086\u003C\u002Ffont\u003E\u003C\u002Fb\u003E\u003C\u002Fp\u003E\u003Cp\u003E\u003Cem\u003EEuropean Journal of Gynaecological Oncology\u003C\u002Fem\u003E (\u003Cem\u003EEJGO\u003C\u002Fem\u003E) is an international, peer-reviewed, open access journal. \u003Cem\u003EEJGO\u003C\u002Fem\u003E publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.\u003Cbr\u003E\u003C\u002Fp\u003E\u003Cp\u003E\u003Cbr\u003E\u003C\u002Fp\u003E,EditorInChief:\u003Cp\u003E\u003Cb\u003EEditor-in-Chief\u003C\u002Fb\u003E\u003C\u002Fp\u003E\u003Cp\u003E\u003Cb\u003E\u003Cbr\u003E\u003C\u002Fb\u003E\u003C\u002Fp\u003E\u003Cp\u003E\u003Cb\u003EProf. Enrique Hernandez, MD, FACOG, FACS.\u003C\u002Fb\u003E\u003C\u002Fp\u003E\u003Cp\u003EDr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.\u003C\u002Fp\u003E}},error:a,state:{fulltext:{xml:a,app:a,figure:}},serverRendered:true}}(null,0,1,6,1515877977256017920,Original Research,1879406382708342784,1754763456389496832,2022-04-18T02:20:48.000+0000,2024-02-06T07:06:24.000+0000,2025-07-17T09:25:01.000+0000,1945002090504830976,2,3,1516316667967094784,Reviews,2021-12-31T16:00:00.000+0000,43,1,2022-04-19T07:24:00.000+0000,1625699010749579264,2025-03-17T07:07:27.000+0000,5,1516226107600191488,2025-01-15T05:52:53.000+0000,2022-04-22T07:54:01.000+0000,2023-12-31T16:00:00.000+0000,45,2022-10-14T06:47:08.000+0000,9,1580787388898000896,2024-04-15T06:53:04.000+0000,2024-10-15T07:21:41.000+0000,2024-02-15T06:49:45.000+0000,1879406383207464960,2023-02-15T03:30:22.000+0000,1527178059624398848,2023-02-15T09:14:42.000+0000,15,2,Case Reports,2022-04-19T01:24:08.000+0000,1625699012133699584,2022-04-22T13:04:33.000+0000,46,2024-12-31T16:00:00.000+0000,1754763456632766464,4,2022-04-14T16:00:00.000+0000,2022-05-19T06:43:17.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F43\u002Fissue\u002FEJGOv43i2.jpg,1846088487911997440,1779763846709166080,1516316668445245440,10,42,2020-12-31T16:00:00.000+0000,44,8,2022-04-21T03:21:53.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F46\u002Fissue\u002FMRE-EJGO-2025v46i1.jpg,2025-01-15T05:52:54.000+0000,2025-01-14T16:00:00.000+0000,2022-06-13T08:32:52.000+0000,2025-02-14T15:27:26.000+0000,2022-12-15T08:07:11.000+0000,116,3,25,2024-06-15T03:41:41.000+0000,18,2024-08-15T07:07:25.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F43\u002Fissue\u002FEJGO-v43i5.png,4,47,13,2022-06-13T08:32:45.000+0000,5,2022-10-14T05:07:37.000+0000,6,2022-10-14T16:00:00.000+0000,2022-04-25T05:46:43.000+0000,19,1517402292606648320,2023-08-15T09:06:55.000+0000,2022-12-31T16:00:00.000+0000,2022-12-30T16:00:00.000+0000,1517046073010339840,1839562836388265984,2022-04-22T07:55:36.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F45\u002Fissue\u002FMRE-EJGO-2024v45i5.jpg,1517402788956389376,2024-10-15T07:19:28.000+0000,2022-04-22T07:17:53.000+0000,Quality of Life in Gynecologic Malignancies ,2025-01-02T01:49:04.000+0000,2024-10-14T16:00:00.000+0000,2025-12-30T16:00:00.000+0000,1808737138669174784,1801481533961191424,Advances in Ovarian Cancer Research,Systematic Review or Meta-Analysis in Gynaecological Oncology,Hysteroscopic-view of endometrial atypical hyperplasia. A helpful diagnostic tool in the care and treatment process?,1516654499067772928,2023-10-30T16:00:00.000+0000,24,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F44\u002Fissue\u002FEJGO 2023v44i1.jpg,2023-02-15T03:30:23.000+0000,2022-10-07T16:00:00.000+0000,1515877978736607232,2023-02-14T16:00:00.000+0000,8.21 MB,1528658354823413760,11,2016-12-31T16:00:00.000+0000,38,123,143,1823956766542446592,115,2024-12-30T16:00:00.000+0000,1536912708776935424,1516668460525862912,Radical Surgery in Ovarian Cancer,2022-06-15T10:33:46.000+0000,1517044789540732928,340,2022-04-22T07:54:09.000+0000,2023-05-08T16:00:00.000+0000,1603262152639954944,Systematic reviews,102,1890297629861920768,315.47 kB,2023-09-14T16:00:00.000+0000,63,341,7,54,2024-02-14T16:00:00.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F45\u002Fissue\u002FMRE-EJGO-v45i1.jpg,45,511,2024-04-14T16:00:00.000+0000,2024-04-15T06:49:02.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F45\u002Fissue\u002FMRE-EJGO-2024v45i2.jpg,1528658584818073600,14,1691366074436468736,141,220,17,2021-02-14T16:00:00.000+0000,2024-12-22T16:00:00.000+0000,https:\u002F\u002Foss.ejgo.net\u002Ffiles\u002Fvolume\u002F42\u002Fissue\u002FEJGO 2021-42-1.jpg));/script>script src/_nuxt/eec1a6e9a5a74f9cf488.js defer>/script>script src/_nuxt/d9cbb78c020534e75640.js defer>/script>script src/_nuxt/db6bf579df3e706bbe99.js defer>/script>script src/_nuxt/86e9591c0a129192ff55.js defer>/script>script src/_nuxt/c4dd8d6bc7da3647faef.js defer>/script>  /body>/html>

Subdomains

Date	Domain	IP
apii.ejgo.net	2022-11-08	13.226.22.2
www.ejgo.net	2025-08-01	3.163.24.79

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.ejgo.net

Is this malicious?

DNS Resolutions

Port 80

Port 443

Subdomains